[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fjSL3AJ6aPEorEw4ptKl_vFhBpY6pzOBsK2CWr5N6HX8":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":85,"rows":92},"Centre Hospitalier Universitaire de Nīmes",[4],582,false,102,9,1838866,26,487,[14,17,20,23,25,28,30,32],{"name":15,"count":16},"Multiple Sclerosis",12,{"name":18,"count":19},"Stroke",11,{"name":21,"count":22},"Low Back Pain",10,{"name":24,"count":9},"Surgery",{"name":26,"count":27},"COVID-19",7,{"name":29,"count":27},"Stress Disorders, Post-Traumatic",{"name":31,"count":27},"Pelvic Organ Prolapse",{"name":33,"count":27},"Cancer",[35,40,45,50,55,60,65,70,75,80],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT04617756","Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract","2025-01-01","Patients receiving neoadjuvant therapy before radical nephrectomy",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT05825573","Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus","2025-02-05","Vitamin K antagonist",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT06827353","Niraparib Versus Bevacizumab as Maintenance Therapy in Patients With de Novo Ovarian Cancer Without Homologous Recombination Deficiency","2025-05-31","maintenance therapy with bevacizumab",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT03636243","Comparative Evaluation of the Evolution of Arterial and Microcirculatory Endothelial Function in Obese Patients With Type-2 Diabetes Versus Non-diabetic Obese Patients After a First Bariatric Surgery","2025-09","Vascularly biological assessment",{"nctId":56,"briefTitle":57,"date":58,"intervention":59},"NCT06082856","Evaluation of the Hemodynamic Effect of Dexmedetomidine in Scheduled Outpatient Surgery","2026-02","Dexmedetomidine",{"nctId":61,"briefTitle":62,"date":63,"intervention":64},"NCT05439902","Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women","2026-03","Tamsulosin",{"nctId":66,"briefTitle":67,"date":68,"intervention":69},"NCT05825560","Opioid-free Analgesia in Intensive Care Unit","2026-05-15","OFA multimodal analgesia",{"nctId":71,"briefTitle":72,"date":73,"intervention":74},"NCT03646058","Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode","2026-10","Buprenorphine",{"nctId":76,"briefTitle":77,"date":78,"intervention":79},"NCT07201012","Determining the Prevalence of Muir-Torre Syndrome in Patients With Lynch Syndrome","2026-11","Constitution of a biobank",{"nctId":81,"briefTitle":82,"date":83,"intervention":84},"NCT07236463","Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury","2027-02-01","Continuous veino-veinous dialysis with iron-chelator supplemented dialysate",[86,87,88,89,90,91],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[93,124,142,166,184,207,231,249,271,298,316,337,362,385,403,427,445,475,493,511,529,547,565,583,601,624,648,674,700,718,743,767,794,812,838,866,884,902,920,946,964,988,1015,1033,1058,1083,1109,1127,1145,1170,1188,1215,1233,1251,1280,1298,1325,1343,1370,1388,1406,1424,1450,1468,1494,1512,1538,1556,1582,1600,1618,1643,1671,1689,1714,1765,1814,1846,1874,1912,1940,1958,1983,2008,2035,2059,2084,2111,2129,2152,2176,2202,2220,2238,2256,2274,2298,2320,2346,2364,2390,2408,2433,2458,2482,2508,2532,2556,2584,2602,2620,2647,2673,2697,2723,2741,2766,2791,2816,2834,2858,2883,2901,2927,2953,2971,2995,3017,3051,3069,3087,3113,3138,3164,3182,3207,3225,3248,3271,3295,3319,3346,3364,3382,3409,3437,3455,3473,3498],{"intervention":94,"totalTrials":95,"cells":96},"Ambulatory surgery under Lidocaine with epinephrine alone",1,{"EARLY_PHASE1":97,"PHASE1":100,"PHASE2":102,"PHASE3":104,"PHASE4":106,"NA":122},{"trials":98,"activeCount":99},[],0,{"trials":101,"activeCount":99},[],{"trials":103,"activeCount":99},[],{"trials":105,"activeCount":99},[],{"trials":107,"activeCount":95,"soonestReadout":83},[108],{"nctId":109,"briefTitle":110,"status":111,"phases":112,"primaryCompletion":83,"completion":83,"start":113,"enrollment":114,"conditions":115,"interventions":120},"NCT07342010","Bicarbonate Addition to Lidocaine-Epinephrine in Surgery Under WALANT","NOT_YET_RECRUITING",[90],"2026-02-01",150,[116,117,118,119],"Anesthesia, Local","Hand Surgery","Foot Surgery","Walant Surgery",[94,121],"Ambulatory surgery under lidocaine with epinephrine plus bicarbonate",{"trials":123,"activeCount":99},[],{"intervention":121,"totalTrials":95,"cells":125},{"EARLY_PHASE1":126,"PHASE1":128,"PHASE2":130,"PHASE3":132,"PHASE4":134,"NA":140},{"trials":127,"activeCount":99},[],{"trials":129,"activeCount":99},[],{"trials":131,"activeCount":99},[],{"trials":133,"activeCount":99},[],{"trials":135,"activeCount":95,"soonestReadout":83},[136],{"nctId":109,"briefTitle":110,"status":111,"phases":137,"primaryCompletion":83,"completion":83,"start":113,"enrollment":114,"conditions":138,"interventions":139},[90],[116,117,118,119],[94,121],{"trials":141,"activeCount":99},[],{"intervention":69,"totalTrials":95,"cells":143},{"EARLY_PHASE1":144,"PHASE1":146,"PHASE2":148,"PHASE3":150,"PHASE4":152,"NA":164},{"trials":145,"activeCount":99},[],{"trials":147,"activeCount":99},[],{"trials":149,"activeCount":99},[],{"trials":151,"activeCount":99},[],{"trials":153,"activeCount":95,"soonestReadout":68},[154],{"nctId":66,"briefTitle":67,"status":155,"phases":156,"primaryCompletion":68,"completion":157,"start":158,"enrollment":159,"conditions":160,"interventions":162},"RECRUITING",[90],"2026-08-15","2023-05-15",50,[161],"Intubation",[69,163],"Standard multimodal analgesia",{"trials":165,"activeCount":99},[],{"intervention":163,"totalTrials":95,"cells":167},{"EARLY_PHASE1":168,"PHASE1":170,"PHASE2":172,"PHASE3":174,"PHASE4":176,"NA":182},{"trials":169,"activeCount":99},[],{"trials":171,"activeCount":99},[],{"trials":173,"activeCount":99},[],{"trials":175,"activeCount":99},[],{"trials":177,"activeCount":95,"soonestReadout":68},[178],{"nctId":66,"briefTitle":67,"status":155,"phases":179,"primaryCompletion":68,"completion":157,"start":158,"enrollment":159,"conditions":180,"interventions":181},[90],[161],[69,163],{"trials":183,"activeCount":99},[],{"intervention":74,"totalTrials":95,"cells":185},{"EARLY_PHASE1":186,"PHASE1":188,"PHASE2":190,"PHASE3":192,"PHASE4":203,"NA":205},{"trials":187,"activeCount":99},[],{"trials":189,"activeCount":99},[],{"trials":191,"activeCount":99},[],{"trials":193,"activeCount":95,"soonestReadout":73},[194],{"nctId":71,"briefTitle":72,"status":155,"phases":195,"primaryCompletion":73,"completion":196,"start":197,"enrollment":198,"conditions":199,"interventions":202},[89],"2027-01","2021-10-10",180,[200,201],"Suicidal Ideation","Major Depressive Episode",[74],{"trials":204,"activeCount":99},[],{"trials":206,"activeCount":99},[],{"intervention":44,"totalTrials":95,"cells":208},{"EARLY_PHASE1":209,"PHASE1":211,"PHASE2":213,"PHASE3":215,"PHASE4":227,"NA":229},{"trials":210,"activeCount":99},[],{"trials":212,"activeCount":99},[],{"trials":214,"activeCount":99},[],{"trials":216,"activeCount":95,"soonestReadout":43},[217],{"nctId":41,"briefTitle":42,"status":218,"phases":219,"primaryCompletion":43,"completion":58,"start":158,"enrollment":220,"conditions":221,"interventions":225},"ACTIVE_NOT_RECRUITING",[89],340,[222,223,224],"Intracardiac Thrombus","STEMI","Heart Failure",[44,226],"Direct oral anticoagulant",{"trials":228,"activeCount":99},[],{"trials":230,"activeCount":99},[],{"intervention":226,"totalTrials":95,"cells":232},{"EARLY_PHASE1":233,"PHASE1":235,"PHASE2":237,"PHASE3":239,"PHASE4":245,"NA":247},{"trials":234,"activeCount":99},[],{"trials":236,"activeCount":99},[],{"trials":238,"activeCount":99},[],{"trials":240,"activeCount":95,"soonestReadout":43},[241],{"nctId":41,"briefTitle":42,"status":218,"phases":242,"primaryCompletion":43,"completion":58,"start":158,"enrollment":220,"conditions":243,"interventions":244},[89],[222,223,224],[44,226],{"trials":246,"activeCount":99},[],{"trials":248,"activeCount":99},[],{"intervention":84,"totalTrials":95,"cells":250},{"EARLY_PHASE1":251,"PHASE1":253,"PHASE2":255,"PHASE3":265,"PHASE4":267,"NA":269},{"trials":252,"activeCount":99},[],{"trials":254,"activeCount":99},[],{"trials":256,"activeCount":95,"soonestReadout":83},[257],{"nctId":81,"briefTitle":82,"status":111,"phases":258,"primaryCompletion":83,"completion":259,"start":113,"enrollment":260,"conditions":261,"interventions":264},[87,88],"2028-05",14,[262,263],"Acute Kidney Injury","Sepsis",[84],{"trials":266,"activeCount":99},[],{"trials":268,"activeCount":99},[],{"trials":270,"activeCount":99},[],{"intervention":272,"totalTrials":95,"cells":273},"Topical anti-Staphylococcus bacteriophage therapy",{"EARLY_PHASE1":274,"PHASE1":276,"PHASE2":278,"PHASE3":292,"PHASE4":294,"NA":296},{"trials":275,"activeCount":99},[],{"trials":277,"activeCount":99},[],{"trials":279,"activeCount":95,"soonestReadout":284},[280],{"nctId":281,"briefTitle":282,"status":111,"phases":283,"primaryCompletion":284,"completion":284,"start":285,"enrollment":286,"conditions":287,"interventions":290},"NCT02664740","Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus",[87,88],"2028-11","2026-09-01",60,[288,289],"Diabetic Foot","Staphylococcal Infections",[272,291],"Topical placebo corresponding to anti-Staphylococcus bacteriophage therapy",{"trials":293,"activeCount":99},[],{"trials":295,"activeCount":99},[],{"trials":297,"activeCount":99},[],{"intervention":291,"totalTrials":95,"cells":299},{"EARLY_PHASE1":300,"PHASE1":302,"PHASE2":304,"PHASE3":310,"PHASE4":312,"NA":314},{"trials":301,"activeCount":99},[],{"trials":303,"activeCount":99},[],{"trials":305,"activeCount":95,"soonestReadout":284},[306],{"nctId":281,"briefTitle":282,"status":111,"phases":307,"primaryCompletion":284,"completion":284,"start":285,"enrollment":286,"conditions":308,"interventions":309},[87,88],[288,289],[272,291],{"trials":311,"activeCount":99},[],{"trials":313,"activeCount":99},[],{"trials":315,"activeCount":99},[],{"intervention":39,"totalTrials":95,"cells":317},{"EARLY_PHASE1":318,"PHASE1":320,"PHASE2":322,"PHASE3":331,"PHASE4":333,"NA":335},{"trials":319,"activeCount":99},[],{"trials":321,"activeCount":99},[],{"trials":323,"activeCount":95,"soonestReadout":38},[324],{"nctId":36,"briefTitle":37,"status":155,"phases":325,"primaryCompletion":38,"completion":326,"start":327,"enrollment":159,"conditions":328,"interventions":330},[88],"2026-10-01","2021-09-29",[329,33],"Urothelial Carcinoma",[39],{"trials":332,"activeCount":99},[],{"trials":334,"activeCount":99},[],{"trials":336,"activeCount":99},[],{"intervention":338,"totalTrials":95,"cells":339},"Protein pump inhibitor therapy systematically",{"EARLY_PHASE1":340,"PHASE1":342,"PHASE2":344,"PHASE3":346,"PHASE4":348,"NA":350},{"trials":341,"activeCount":99},[],{"trials":343,"activeCount":99},[],{"trials":345,"activeCount":99},[],{"trials":347,"activeCount":99},[],{"trials":349,"activeCount":99},[],{"trials":351,"activeCount":95,"soonestReadout":356},[352],{"nctId":353,"briefTitle":354,"status":155,"phases":355,"primaryCompletion":356,"completion":356,"start":357,"enrollment":358,"conditions":359,"interventions":361},"NCT05899842","Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia",[91],"2028-02","2023-06-01",132,[360],"Esophageal Achalasia",[338],{"intervention":49,"totalTrials":95,"cells":363},{"EARLY_PHASE1":364,"PHASE1":366,"PHASE2":368,"PHASE3":370,"PHASE4":372,"NA":374},{"trials":365,"activeCount":99},[],{"trials":367,"activeCount":99},[],{"trials":369,"activeCount":99},[],{"trials":371,"activeCount":99},[],{"trials":373,"activeCount":99},[],{"trials":375,"activeCount":95,"soonestReadout":48},[376],{"nctId":46,"briefTitle":47,"status":155,"phases":377,"primaryCompletion":48,"completion":378,"start":379,"enrollment":380,"conditions":381,"interventions":383},[],"2025-09-30","2020-10-01",300,[382],"Ovarian Carcinoma",[49,384],"maintenance therapy with niraparib",{"intervention":384,"totalTrials":95,"cells":386},{"EARLY_PHASE1":387,"PHASE1":389,"PHASE2":391,"PHASE3":393,"PHASE4":395,"NA":397},{"trials":388,"activeCount":99},[],{"trials":390,"activeCount":99},[],{"trials":392,"activeCount":99},[],{"trials":394,"activeCount":99},[],{"trials":396,"activeCount":99},[],{"trials":398,"activeCount":95,"soonestReadout":48},[399],{"nctId":46,"briefTitle":47,"status":155,"phases":400,"primaryCompletion":48,"completion":378,"start":379,"enrollment":380,"conditions":401,"interventions":402},[],[382],[49,384],{"intervention":59,"totalTrials":95,"cells":404},{"EARLY_PHASE1":405,"PHASE1":407,"PHASE2":409,"PHASE3":411,"PHASE4":413,"NA":415},{"trials":406,"activeCount":99},[],{"trials":408,"activeCount":99},[],{"trials":410,"activeCount":99},[],{"trials":412,"activeCount":99},[],{"trials":414,"activeCount":99},[],{"trials":416,"activeCount":95,"soonestReadout":58},[417],{"nctId":56,"briefTitle":57,"status":155,"phases":418,"primaryCompletion":58,"completion":58,"start":419,"enrollment":420,"conditions":421,"interventions":425},[91],"2023-10-19",594,[422,59,423,424],"Anesthesia","Hemodynamics","Ambulatory Care",[59,426],"Sufentanil",{"intervention":426,"totalTrials":95,"cells":428},{"EARLY_PHASE1":429,"PHASE1":431,"PHASE2":433,"PHASE3":435,"PHASE4":437,"NA":439},{"trials":430,"activeCount":99},[],{"trials":432,"activeCount":99},[],{"trials":434,"activeCount":99},[],{"trials":436,"activeCount":99},[],{"trials":438,"activeCount":99},[],{"trials":440,"activeCount":95,"soonestReadout":58},[441],{"nctId":56,"briefTitle":57,"status":155,"phases":442,"primaryCompletion":58,"completion":58,"start":419,"enrollment":420,"conditions":443,"interventions":444},[91],[422,59,423,424],[59,426],{"intervention":54,"totalTrials":95,"cells":446},{"EARLY_PHASE1":447,"PHASE1":449,"PHASE2":451,"PHASE3":453,"PHASE4":455,"NA":457},{"trials":448,"activeCount":99},[],{"trials":450,"activeCount":99},[],{"trials":452,"activeCount":99},[],{"trials":454,"activeCount":99},[],{"trials":456,"activeCount":99},[],{"trials":458,"activeCount":95,"soonestReadout":53},[459],{"nctId":51,"briefTitle":52,"status":218,"phases":460,"primaryCompletion":53,"completion":53,"start":461,"enrollment":462,"conditions":463,"interventions":467},[91],"2019-10-15",37,[464,465,466],"Bariatric Surgery","Obese","Type2 Diabetes",[54,468,469,470,471,472,473,474],"Analysis of vasomotor endothelial function","Analysis of arterial compliance","Exploration of microcirculation","Venous Doppler Ultrasound","Arterial pressure measurement","Intima-Media Thickness measurement","Exploration of neuropathy",{"intervention":468,"totalTrials":95,"cells":476},{"EARLY_PHASE1":477,"PHASE1":479,"PHASE2":481,"PHASE3":483,"PHASE4":485,"NA":487},{"trials":478,"activeCount":99},[],{"trials":480,"activeCount":99},[],{"trials":482,"activeCount":99},[],{"trials":484,"activeCount":99},[],{"trials":486,"activeCount":99},[],{"trials":488,"activeCount":95,"soonestReadout":53},[489],{"nctId":51,"briefTitle":52,"status":218,"phases":490,"primaryCompletion":53,"completion":53,"start":461,"enrollment":462,"conditions":491,"interventions":492},[91],[464,465,466],[54,468,469,470,471,472,473,474],{"intervention":469,"totalTrials":95,"cells":494},{"EARLY_PHASE1":495,"PHASE1":497,"PHASE2":499,"PHASE3":501,"PHASE4":503,"NA":505},{"trials":496,"activeCount":99},[],{"trials":498,"activeCount":99},[],{"trials":500,"activeCount":99},[],{"trials":502,"activeCount":99},[],{"trials":504,"activeCount":99},[],{"trials":506,"activeCount":95,"soonestReadout":53},[507],{"nctId":51,"briefTitle":52,"status":218,"phases":508,"primaryCompletion":53,"completion":53,"start":461,"enrollment":462,"conditions":509,"interventions":510},[91],[464,465,466],[54,468,469,470,471,472,473,474],{"intervention":470,"totalTrials":95,"cells":512},{"EARLY_PHASE1":513,"PHASE1":515,"PHASE2":517,"PHASE3":519,"PHASE4":521,"NA":523},{"trials":514,"activeCount":99},[],{"trials":516,"activeCount":99},[],{"trials":518,"activeCount":99},[],{"trials":520,"activeCount":99},[],{"trials":522,"activeCount":99},[],{"trials":524,"activeCount":95,"soonestReadout":53},[525],{"nctId":51,"briefTitle":52,"status":218,"phases":526,"primaryCompletion":53,"completion":53,"start":461,"enrollment":462,"conditions":527,"interventions":528},[91],[464,465,466],[54,468,469,470,471,472,473,474],{"intervention":471,"totalTrials":95,"cells":530},{"EARLY_PHASE1":531,"PHASE1":533,"PHASE2":535,"PHASE3":537,"PHASE4":539,"NA":541},{"trials":532,"activeCount":99},[],{"trials":534,"activeCount":99},[],{"trials":536,"activeCount":99},[],{"trials":538,"activeCount":99},[],{"trials":540,"activeCount":99},[],{"trials":542,"activeCount":95,"soonestReadout":53},[543],{"nctId":51,"briefTitle":52,"status":218,"phases":544,"primaryCompletion":53,"completion":53,"start":461,"enrollment":462,"conditions":545,"interventions":546},[91],[464,465,466],[54,468,469,470,471,472,473,474],{"intervention":472,"totalTrials":95,"cells":548},{"EARLY_PHASE1":549,"PHASE1":551,"PHASE2":553,"PHASE3":555,"PHASE4":557,"NA":559},{"trials":550,"activeCount":99},[],{"trials":552,"activeCount":99},[],{"trials":554,"activeCount":99},[],{"trials":556,"activeCount":99},[],{"trials":558,"activeCount":99},[],{"trials":560,"activeCount":95,"soonestReadout":53},[561],{"nctId":51,"briefTitle":52,"status":218,"phases":562,"primaryCompletion":53,"completion":53,"start":461,"enrollment":462,"conditions":563,"interventions":564},[91],[464,465,466],[54,468,469,470,471,472,473,474],{"intervention":473,"totalTrials":95,"cells":566},{"EARLY_PHASE1":567,"PHASE1":569,"PHASE2":571,"PHASE3":573,"PHASE4":575,"NA":577},{"trials":568,"activeCount":99},[],{"trials":570,"activeCount":99},[],{"trials":572,"activeCount":99},[],{"trials":574,"activeCount":99},[],{"trials":576,"activeCount":99},[],{"trials":578,"activeCount":95,"soonestReadout":53},[579],{"nctId":51,"briefTitle":52,"status":218,"phases":580,"primaryCompletion":53,"completion":53,"start":461,"enrollment":462,"conditions":581,"interventions":582},[91],[464,465,466],[54,468,469,470,471,472,473,474],{"intervention":474,"totalTrials":95,"cells":584},{"EARLY_PHASE1":585,"PHASE1":587,"PHASE2":589,"PHASE3":591,"PHASE4":593,"NA":595},{"trials":586,"activeCount":99},[],{"trials":588,"activeCount":99},[],{"trials":590,"activeCount":99},[],{"trials":592,"activeCount":99},[],{"trials":594,"activeCount":99},[],{"trials":596,"activeCount":95,"soonestReadout":53},[597],{"nctId":51,"briefTitle":52,"status":218,"phases":598,"primaryCompletion":53,"completion":53,"start":461,"enrollment":462,"conditions":599,"interventions":600},[91],[464,465,466],[54,468,469,470,471,472,473,474],{"intervention":64,"totalTrials":95,"cells":602},{"EARLY_PHASE1":603,"PHASE1":605,"PHASE2":607,"PHASE3":609,"PHASE4":611,"NA":613},{"trials":604,"activeCount":99},[],{"trials":606,"activeCount":99},[],{"trials":608,"activeCount":99},[],{"trials":610,"activeCount":99},[],{"trials":612,"activeCount":99},[],{"trials":614,"activeCount":95,"soonestReadout":63},[615],{"nctId":61,"briefTitle":62,"status":155,"phases":616,"primaryCompletion":63,"completion":63,"start":617,"enrollment":286,"conditions":618,"interventions":623},[91],"2022-10-05",[15,619,620,621,622],"Dysuria","Lower Urinary Tract Symptoms","Voiding Dysfunction","Urinary Retention",[64],{"intervention":79,"totalTrials":95,"cells":625},{"EARLY_PHASE1":626,"PHASE1":628,"PHASE2":630,"PHASE3":632,"PHASE4":634,"NA":636},{"trials":627,"activeCount":99},[],{"trials":629,"activeCount":99},[],{"trials":631,"activeCount":99},[],{"trials":633,"activeCount":99},[],{"trials":635,"activeCount":99},[],{"trials":637,"activeCount":95,"soonestReadout":78},[638],{"nctId":76,"briefTitle":77,"status":111,"phases":639,"primaryCompletion":78,"completion":640,"start":641,"enrollment":114,"conditions":642,"interventions":647},[91],"2027-12","2025-12",[643,644,645,646],"Basal Cell Carcinoma of Skin, Site Unspecified","Epidermoid Carcinoma","Lynch Syndrome","Muir-Torre Syndrome",[79],{"intervention":649,"totalTrials":95,"cells":650},"Use of MEOPA during suturing",{"EARLY_PHASE1":651,"PHASE1":653,"PHASE2":655,"PHASE3":657,"PHASE4":659,"NA":672},{"trials":652,"activeCount":99},[],{"trials":654,"activeCount":99},[],{"trials":656,"activeCount":99},[],{"trials":658,"activeCount":99},[],{"trials":660,"activeCount":99},[661],{"nctId":662,"briefTitle":663,"status":664,"phases":665,"primaryCompletion":666,"completion":667,"start":668,"enrollment":286,"conditions":669,"interventions":671},"NCT02420002","Pediatric Emergency Suture Care: a Trial Comparing the Analgesic Efficacy of Hypnosis Versus MEOPA","COMPLETED",[90],"2024-12-31","2025-03-24","2016-10-25",[670],"Wounds, Nonpenetrating",[649],{"trials":673,"activeCount":99},[],{"intervention":675,"totalTrials":95,"cells":676},"Reference",{"EARLY_PHASE1":677,"PHASE1":679,"PHASE2":681,"PHASE3":683,"PHASE4":685,"NA":698},{"trials":678,"activeCount":99},[],{"trials":680,"activeCount":99},[],{"trials":682,"activeCount":99},[],{"trials":684,"activeCount":99},[],{"trials":686,"activeCount":99},[687],{"nctId":688,"briefTitle":689,"status":690,"phases":691,"primaryCompletion":692,"completion":692,"start":693,"enrollment":99,"conditions":694,"interventions":696},"NCT01211431","Post-cesarean Pain Control Via Continuous Infusion of Ropivacain et Diclogenac Into the Wound Versus Intathecal Morphine","WITHDRAWN",[90],"2012-10","2010-09",[695],"Cesarean Section",[675,697],"Experimental",{"trials":699,"activeCount":99},[],{"intervention":697,"totalTrials":95,"cells":701},{"EARLY_PHASE1":702,"PHASE1":704,"PHASE2":706,"PHASE3":708,"PHASE4":710,"NA":716},{"trials":703,"activeCount":99},[],{"trials":705,"activeCount":99},[],{"trials":707,"activeCount":99},[],{"trials":709,"activeCount":99},[],{"trials":711,"activeCount":99},[712],{"nctId":688,"briefTitle":689,"status":690,"phases":713,"primaryCompletion":692,"completion":692,"start":693,"enrollment":99,"conditions":714,"interventions":715},[90],[695],[675,697],{"trials":717,"activeCount":99},[],{"intervention":719,"totalTrials":95,"cells":720},"Ropivacaine",{"EARLY_PHASE1":721,"PHASE1":723,"PHASE2":725,"PHASE3":727,"PHASE4":729,"NA":741},{"trials":722,"activeCount":99},[],{"trials":724,"activeCount":99},[],{"trials":726,"activeCount":99},[],{"trials":728,"activeCount":99},[],{"trials":730,"activeCount":99},[731],{"nctId":732,"briefTitle":733,"status":664,"phases":734,"primaryCompletion":735,"completion":735,"start":736,"enrollment":737,"conditions":738,"interventions":740},"NCT01541059","Postoperative Analgesia Following Wisdom Teeth Removal: Ropivacaine Versus Placebo",[90],"2015-08-29","2012-06",100,[739],"Third Molar Extraction",[719],{"trials":742,"activeCount":99},[],{"intervention":744,"totalTrials":95,"cells":745},"30 mg\u002Fkg amikacin or 8 mg\u002Fkg gentamicin",{"EARLY_PHASE1":746,"PHASE1":748,"PHASE2":750,"PHASE3":752,"PHASE4":754,"NA":765},{"trials":747,"activeCount":99},[],{"trials":749,"activeCount":99},[],{"trials":751,"activeCount":99},[],{"trials":753,"activeCount":99},[],{"trials":755,"activeCount":99},[756],{"nctId":757,"briefTitle":758,"status":664,"phases":759,"primaryCompletion":760,"completion":760,"start":761,"enrollment":762,"conditions":763,"interventions":764},"NCT02898961","Impact of 30 mg\u002Fkg Amikacin and 8 mg\u002Fkg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis",[90],"2016-12-31","2014-10",63,[263],[744],{"trials":766,"activeCount":99},[],{"intervention":768,"totalTrials":95,"cells":769},"Desflurane",{"EARLY_PHASE1":770,"PHASE1":772,"PHASE2":774,"PHASE3":776,"PHASE4":778,"NA":792},{"trials":771,"activeCount":99},[],{"trials":773,"activeCount":99},[],{"trials":775,"activeCount":99},[],{"trials":777,"activeCount":99},[],{"trials":779,"activeCount":99},[780],{"nctId":781,"briefTitle":782,"status":664,"phases":783,"primaryCompletion":784,"completion":785,"start":786,"enrollment":787,"conditions":788,"interventions":790},"NCT01167803","Anesthesia for Obese Patients: Desflurane Versus Xenon",[90],"2012-11","2012-12","2010-12",192,[789],"Obesity",[768,791],"Xenon",{"trials":793,"activeCount":99},[],{"intervention":791,"totalTrials":95,"cells":795},{"EARLY_PHASE1":796,"PHASE1":798,"PHASE2":800,"PHASE3":802,"PHASE4":804,"NA":810},{"trials":797,"activeCount":99},[],{"trials":799,"activeCount":99},[],{"trials":801,"activeCount":99},[],{"trials":803,"activeCount":99},[],{"trials":805,"activeCount":99},[806],{"nctId":781,"briefTitle":782,"status":664,"phases":807,"primaryCompletion":784,"completion":785,"start":786,"enrollment":787,"conditions":808,"interventions":809},[90],[789],[768,791],{"trials":811,"activeCount":99},[],{"intervention":813,"totalTrials":95,"cells":814},"Echinocandins",{"EARLY_PHASE1":815,"PHASE1":817,"PHASE2":819,"PHASE3":821,"PHASE4":823,"NA":836},{"trials":816,"activeCount":99},[],{"trials":818,"activeCount":99},[],{"trials":820,"activeCount":99},[],{"trials":822,"activeCount":99},[],{"trials":824,"activeCount":99},[825],{"nctId":826,"briefTitle":827,"status":664,"phases":828,"primaryCompletion":829,"completion":829,"start":830,"enrollment":831,"conditions":832,"interventions":835},"NCT02805049","Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis (EPI Study)",[90],"2018-06-18","2017-01-28",24,[833,834],"Septic Shock","Peritonitis",[813],{"trials":837,"activeCount":99},[],{"intervention":839,"totalTrials":95,"cells":840},"Tramadol",{"EARLY_PHASE1":841,"PHASE1":843,"PHASE2":845,"PHASE3":847,"PHASE4":849,"NA":864},{"trials":842,"activeCount":99},[],{"trials":844,"activeCount":99},[],{"trials":846,"activeCount":99},[],{"trials":848,"activeCount":99},[],{"trials":850,"activeCount":99},[851],{"nctId":852,"briefTitle":853,"status":664,"phases":854,"primaryCompletion":855,"completion":855,"start":856,"enrollment":857,"conditions":858,"interventions":860},"NCT04110665","Multimodal Analgesia Strategies After Major Shoulder Ambulatory Surgery",[90],"2019-09-26","2017-09-01",92,[859],"Tendon Injuries",[839,861,862,863],"Nefopam 20 MG\u002FML","Morphine Sulfate","Oxycodone 20mg",{"trials":865,"activeCount":99},[],{"intervention":861,"totalTrials":95,"cells":867},{"EARLY_PHASE1":868,"PHASE1":870,"PHASE2":872,"PHASE3":874,"PHASE4":876,"NA":882},{"trials":869,"activeCount":99},[],{"trials":871,"activeCount":99},[],{"trials":873,"activeCount":99},[],{"trials":875,"activeCount":99},[],{"trials":877,"activeCount":99},[878],{"nctId":852,"briefTitle":853,"status":664,"phases":879,"primaryCompletion":855,"completion":855,"start":856,"enrollment":857,"conditions":880,"interventions":881},[90],[859],[839,861,862,863],{"trials":883,"activeCount":99},[],{"intervention":862,"totalTrials":95,"cells":885},{"EARLY_PHASE1":886,"PHASE1":888,"PHASE2":890,"PHASE3":892,"PHASE4":894,"NA":900},{"trials":887,"activeCount":99},[],{"trials":889,"activeCount":99},[],{"trials":891,"activeCount":99},[],{"trials":893,"activeCount":99},[],{"trials":895,"activeCount":99},[896],{"nctId":852,"briefTitle":853,"status":664,"phases":897,"primaryCompletion":855,"completion":855,"start":856,"enrollment":857,"conditions":898,"interventions":899},[90],[859],[839,861,862,863],{"trials":901,"activeCount":99},[],{"intervention":863,"totalTrials":95,"cells":903},{"EARLY_PHASE1":904,"PHASE1":906,"PHASE2":908,"PHASE3":910,"PHASE4":912,"NA":918},{"trials":905,"activeCount":99},[],{"trials":907,"activeCount":99},[],{"trials":909,"activeCount":99},[],{"trials":911,"activeCount":99},[],{"trials":913,"activeCount":99},[914],{"nctId":852,"briefTitle":853,"status":664,"phases":915,"primaryCompletion":855,"completion":855,"start":856,"enrollment":857,"conditions":916,"interventions":917},[90],[859],[839,861,862,863],{"trials":919,"activeCount":99},[],{"intervention":921,"totalTrials":95,"cells":922},"Intravenous ketoprofen",{"EARLY_PHASE1":923,"PHASE1":925,"PHASE2":927,"PHASE3":929,"PHASE4":931,"NA":944},{"trials":924,"activeCount":99},[],{"trials":926,"activeCount":99},[],{"trials":928,"activeCount":99},[],{"trials":930,"activeCount":99},[],{"trials":932,"activeCount":99},[933],{"nctId":934,"briefTitle":935,"status":690,"phases":936,"primaryCompletion":937,"completion":937,"start":938,"enrollment":99,"conditions":939,"interventions":942},"NCT01685658","Intravenous Paracetamol Versus Ketoprofen When Treating Renal Colic in Emergency Situations",[90],"2018-03","2016-09",[940,941],"Renal Colic","Acute Renal Colic",[921,943],"Intravenous paracetamol",{"trials":945,"activeCount":99},[],{"intervention":943,"totalTrials":95,"cells":947},{"EARLY_PHASE1":948,"PHASE1":950,"PHASE2":952,"PHASE3":954,"PHASE4":956,"NA":962},{"trials":949,"activeCount":99},[],{"trials":951,"activeCount":99},[],{"trials":953,"activeCount":99},[],{"trials":955,"activeCount":99},[],{"trials":957,"activeCount":99},[958],{"nctId":934,"briefTitle":935,"status":690,"phases":959,"primaryCompletion":937,"completion":937,"start":938,"enrollment":99,"conditions":960,"interventions":961},[90],[940,941],[921,943],{"trials":963,"activeCount":99},[],{"intervention":965,"totalTrials":95,"cells":966},"Vitamin D supplementation",{"EARLY_PHASE1":967,"PHASE1":969,"PHASE2":971,"PHASE3":973,"PHASE4":975,"NA":986},{"trials":968,"activeCount":99},[],{"trials":970,"activeCount":99},[],{"trials":972,"activeCount":99},[],{"trials":974,"activeCount":99},[],{"trials":976,"activeCount":99},[977],{"nctId":978,"briefTitle":979,"status":664,"phases":980,"primaryCompletion":981,"completion":981,"start":982,"enrollment":983,"conditions":984,"interventions":985},"NCT02400151","Vascular and Metabolic Effects of Vitamin D Supplementation Associated With Lifestyle Management in Obese Adolescents",[90],"2016-07-04","2015-03-30",49,[789],[965],{"trials":987,"activeCount":99},[],{"intervention":989,"totalTrials":95,"cells":990},"Vitamin K antagonist or direct oral anticoagulant treatment",{"EARLY_PHASE1":991,"PHASE1":993,"PHASE2":995,"PHASE3":997,"PHASE4":999,"NA":1013},{"trials":992,"activeCount":99},[],{"trials":994,"activeCount":99},[],{"trials":996,"activeCount":99},[],{"trials":998,"activeCount":99},[],{"trials":1000,"activeCount":99},[1001],{"nctId":1002,"briefTitle":1003,"status":664,"phases":1004,"primaryCompletion":1005,"completion":1006,"start":1007,"enrollment":1008,"conditions":1009,"interventions":1011},"NCT02735902","Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions (1:1)",[90],"2023-02-02","2024-01-19","2017-06-01",170,[1010],"Transcatheter Aortic Valve Replacement",[989,1012],"Aspirin",{"trials":1014,"activeCount":99},[],{"intervention":1012,"totalTrials":95,"cells":1016},{"EARLY_PHASE1":1017,"PHASE1":1019,"PHASE2":1021,"PHASE3":1023,"PHASE4":1025,"NA":1031},{"trials":1018,"activeCount":99},[],{"trials":1020,"activeCount":99},[],{"trials":1022,"activeCount":99},[],{"trials":1024,"activeCount":99},[],{"trials":1026,"activeCount":99},[1027],{"nctId":1002,"briefTitle":1003,"status":664,"phases":1028,"primaryCompletion":1005,"completion":1006,"start":1007,"enrollment":1008,"conditions":1029,"interventions":1030},[90],[1010],[989,1012],{"trials":1032,"activeCount":99},[],{"intervention":1034,"totalTrials":95,"cells":1035},"rFVIIa",{"EARLY_PHASE1":1036,"PHASE1":1038,"PHASE2":1040,"PHASE3":1042,"PHASE4":1044,"NA":1056},{"trials":1037,"activeCount":99},[],{"trials":1039,"activeCount":99},[],{"trials":1041,"activeCount":99},[],{"trials":1043,"activeCount":99},[],{"trials":1045,"activeCount":99},[1046],{"nctId":1047,"briefTitle":1048,"status":664,"phases":1049,"primaryCompletion":1050,"completion":1050,"start":1051,"enrollment":1052,"conditions":1053,"interventions":1055},"NCT00370877","rhuFVIIa in Post-partum Hemorrhage",[90],"2010-11","2007-04",84,[1054],"Postpartum Hemorrhage",[1034],{"trials":1057,"activeCount":99},[],{"intervention":1059,"totalTrials":95,"cells":1060},"equimolar oxygen-nitrous oxide mixture",{"EARLY_PHASE1":1061,"PHASE1":1063,"PHASE2":1065,"PHASE3":1067,"PHASE4":1069,"NA":1081},{"trials":1062,"activeCount":99},[],{"trials":1064,"activeCount":99},[],{"trials":1066,"activeCount":99},[],{"trials":1068,"activeCount":99},[],{"trials":1070,"activeCount":99},[1071],{"nctId":1072,"briefTitle":1073,"status":664,"phases":1074,"primaryCompletion":1075,"completion":1075,"start":1076,"enrollment":1077,"conditions":1078,"interventions":1080},"NCT01087229","Effectiveness of an Oxygen-nitrous Oxide Mixture During Physical Therapy for Frozen Shoulder",[90],"2013-09-02","2010-03",75,[1079],"Adhesive Capsulitis",[1059],{"trials":1082,"activeCount":99},[],{"intervention":1084,"totalTrials":95,"cells":1085},"0.5 µg\u002Fkg remifentanil",{"EARLY_PHASE1":1086,"PHASE1":1088,"PHASE2":1090,"PHASE3":1092,"PHASE4":1094,"NA":1107},{"trials":1087,"activeCount":99},[],{"trials":1089,"activeCount":99},[],{"trials":1091,"activeCount":99},[],{"trials":1093,"activeCount":99},[],{"trials":1095,"activeCount":99},[1096],{"nctId":1097,"briefTitle":1098,"status":664,"phases":1099,"primaryCompletion":1100,"completion":1100,"start":1101,"enrollment":1077,"conditions":1102,"interventions":1104},"NCT01259648","Study Evaluating the Efficacy and Safety of Remifentanil in a Rapid Sequence Induction for Fragile Subjects",[90],"2014-05-20","2011-03-09",[1103],"Tachycardia",[1084,1105,1106],"1.0 µg\u002Fkg remifentanil","NaCl",{"trials":1108,"activeCount":99},[],{"intervention":1105,"totalTrials":95,"cells":1110},{"EARLY_PHASE1":1111,"PHASE1":1113,"PHASE2":1115,"PHASE3":1117,"PHASE4":1119,"NA":1125},{"trials":1112,"activeCount":99},[],{"trials":1114,"activeCount":99},[],{"trials":1116,"activeCount":99},[],{"trials":1118,"activeCount":99},[],{"trials":1120,"activeCount":99},[1121],{"nctId":1097,"briefTitle":1098,"status":664,"phases":1122,"primaryCompletion":1100,"completion":1100,"start":1101,"enrollment":1077,"conditions":1123,"interventions":1124},[90],[1103],[1084,1105,1106],{"trials":1126,"activeCount":99},[],{"intervention":1106,"totalTrials":95,"cells":1128},{"EARLY_PHASE1":1129,"PHASE1":1131,"PHASE2":1133,"PHASE3":1135,"PHASE4":1137,"NA":1143},{"trials":1130,"activeCount":99},[],{"trials":1132,"activeCount":99},[],{"trials":1134,"activeCount":99},[],{"trials":1136,"activeCount":99},[],{"trials":1138,"activeCount":99},[1139],{"nctId":1097,"briefTitle":1098,"status":664,"phases":1140,"primaryCompletion":1100,"completion":1100,"start":1101,"enrollment":1077,"conditions":1141,"interventions":1142},[90],[1103],[1084,1105,1106],{"trials":1144,"activeCount":99},[],{"intervention":1146,"totalTrials":95,"cells":1147},"Standard Care morphine hydrochloride",{"EARLY_PHASE1":1148,"PHASE1":1150,"PHASE2":1152,"PHASE3":1154,"PHASE4":1156,"NA":1168},{"trials":1149,"activeCount":99},[],{"trials":1151,"activeCount":99},[],{"trials":1153,"activeCount":99},[],{"trials":1155,"activeCount":99},[],{"trials":1157,"activeCount":99},[1158],{"nctId":1159,"briefTitle":1160,"status":664,"phases":1161,"primaryCompletion":1162,"completion":1162,"start":736,"enrollment":1163,"conditions":1164,"interventions":1166},"NCT01536301","Oxycodone Versus Intravenous Morphine for Postoperative Analgesia After Hip Surgery",[90],"2016-11-15",246,[1165],"Arthroplasty, Replacement, Hip",[1146,1167],"Oxycodone",{"trials":1169,"activeCount":99},[],{"intervention":1167,"totalTrials":95,"cells":1171},{"EARLY_PHASE1":1172,"PHASE1":1174,"PHASE2":1176,"PHASE3":1178,"PHASE4":1180,"NA":1186},{"trials":1173,"activeCount":99},[],{"trials":1175,"activeCount":99},[],{"trials":1177,"activeCount":99},[],{"trials":1179,"activeCount":99},[],{"trials":1181,"activeCount":99},[1182],{"nctId":1159,"briefTitle":1160,"status":664,"phases":1183,"primaryCompletion":1162,"completion":1162,"start":736,"enrollment":1163,"conditions":1184,"interventions":1185},[90],[1165],[1146,1167],{"trials":1187,"activeCount":99},[],{"intervention":1189,"totalTrials":95,"cells":1190},"Hydration strategy using saline",{"EARLY_PHASE1":1191,"PHASE1":1193,"PHASE2":1195,"PHASE3":1197,"PHASE4":1211,"NA":1213},{"trials":1192,"activeCount":99},[],{"trials":1194,"activeCount":99},[],{"trials":1196,"activeCount":99},[],{"trials":1198,"activeCount":99},[1199],{"nctId":1200,"briefTitle":1201,"status":1202,"phases":1203,"primaryCompletion":1204,"completion":1204,"start":1205,"enrollment":9,"conditions":1206,"interventions":1208},"NCT01786824","Preventing Contrast-induced Nephropathy: Evaluating Hydration Strategies and L-carnitine Administration","TERMINATED",[89],"2015-08","2014-12",[262,1207],"Renal Insufficiency",[1189,1209,1210],"Hydration strategy using sodium bicarbonate","L-carnitine",{"trials":1212,"activeCount":99},[],{"trials":1214,"activeCount":99},[],{"intervention":1209,"totalTrials":95,"cells":1216},{"EARLY_PHASE1":1217,"PHASE1":1219,"PHASE2":1221,"PHASE3":1223,"PHASE4":1229,"NA":1231},{"trials":1218,"activeCount":99},[],{"trials":1220,"activeCount":99},[],{"trials":1222,"activeCount":99},[],{"trials":1224,"activeCount":99},[1225],{"nctId":1200,"briefTitle":1201,"status":1202,"phases":1226,"primaryCompletion":1204,"completion":1204,"start":1205,"enrollment":9,"conditions":1227,"interventions":1228},[89],[262,1207],[1189,1209,1210],{"trials":1230,"activeCount":99},[],{"trials":1232,"activeCount":99},[],{"intervention":1210,"totalTrials":95,"cells":1234},{"EARLY_PHASE1":1235,"PHASE1":1237,"PHASE2":1239,"PHASE3":1241,"PHASE4":1247,"NA":1249},{"trials":1236,"activeCount":99},[],{"trials":1238,"activeCount":99},[],{"trials":1240,"activeCount":99},[],{"trials":1242,"activeCount":99},[1243],{"nctId":1200,"briefTitle":1201,"status":1202,"phases":1244,"primaryCompletion":1204,"completion":1204,"start":1205,"enrollment":9,"conditions":1245,"interventions":1246},[89],[262,1207],[1189,1209,1210],{"trials":1248,"activeCount":99},[],{"trials":1250,"activeCount":99},[],{"intervention":1252,"totalTrials":95,"cells":1253},"Local administration of ropivacaine",{"EARLY_PHASE1":1254,"PHASE1":1256,"PHASE2":1258,"PHASE3":1260,"PHASE4":1276,"NA":1278},{"trials":1255,"activeCount":99},[],{"trials":1257,"activeCount":99},[],{"trials":1259,"activeCount":99},[],{"trials":1261,"activeCount":99},[1262],{"nctId":1263,"briefTitle":1264,"status":664,"phases":1265,"primaryCompletion":1266,"completion":1267,"start":1268,"enrollment":159,"conditions":1269,"interventions":1274},"NCT04473508","Erectus Nerve Block for Lumbar Spine Surgery",[89],"2021-06-25","2021-09-09","2019-11-27",[1270,1271,1272,1273],"Spine Surgery","Pain Relief","Morphine","AdverseEvent",[1252,1275],"Local administration of placebo",{"trials":1277,"activeCount":99},[],{"trials":1279,"activeCount":99},[],{"intervention":1275,"totalTrials":95,"cells":1281},{"EARLY_PHASE1":1282,"PHASE1":1284,"PHASE2":1286,"PHASE3":1288,"PHASE4":1294,"NA":1296},{"trials":1283,"activeCount":99},[],{"trials":1285,"activeCount":99},[],{"trials":1287,"activeCount":99},[],{"trials":1289,"activeCount":99},[1290],{"nctId":1263,"briefTitle":1264,"status":664,"phases":1291,"primaryCompletion":1266,"completion":1267,"start":1268,"enrollment":159,"conditions":1292,"interventions":1293},[89],[1270,1271,1272,1273],[1252,1275],{"trials":1295,"activeCount":99},[],{"trials":1297,"activeCount":99},[],{"intervention":1299,"totalTrials":95,"cells":1300},"Lumbar puncture",{"EARLY_PHASE1":1301,"PHASE1":1303,"PHASE2":1305,"PHASE3":1307,"PHASE4":1321,"NA":1323},{"trials":1302,"activeCount":99},[],{"trials":1304,"activeCount":99},[],{"trials":1306,"activeCount":99},[],{"trials":1308,"activeCount":99},[1309],{"nctId":1310,"briefTitle":1311,"status":664,"phases":1312,"primaryCompletion":1313,"completion":1313,"start":1314,"enrollment":1315,"conditions":1316,"interventions":1317},"NCT01817166","Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated Syndrome",[89],"2023-01-04","2013-07-16",316,[15],[1318,1299,1319,1320],"Vitamin D","Blood sampling","Urine samples",{"trials":1322,"activeCount":99},[],{"trials":1324,"activeCount":99},[],{"intervention":1320,"totalTrials":95,"cells":1326},{"EARLY_PHASE1":1327,"PHASE1":1329,"PHASE2":1331,"PHASE3":1333,"PHASE4":1339,"NA":1341},{"trials":1328,"activeCount":99},[],{"trials":1330,"activeCount":99},[],{"trials":1332,"activeCount":99},[],{"trials":1334,"activeCount":99},[1335],{"nctId":1310,"briefTitle":1311,"status":664,"phases":1336,"primaryCompletion":1313,"completion":1313,"start":1314,"enrollment":1315,"conditions":1337,"interventions":1338},[89],[15],[1318,1299,1319,1320],{"trials":1340,"activeCount":99},[],{"trials":1342,"activeCount":99},[],{"intervention":1344,"totalTrials":95,"cells":1345},"1st perfusion of ketamine",{"EARLY_PHASE1":1346,"PHASE1":1348,"PHASE2":1350,"PHASE3":1352,"PHASE4":1366,"NA":1368},{"trials":1347,"activeCount":99},[],{"trials":1349,"activeCount":99},[],{"trials":1351,"activeCount":99},[],{"trials":1353,"activeCount":99},[1354],{"nctId":1355,"briefTitle":1356,"status":664,"phases":1357,"primaryCompletion":1358,"completion":1358,"start":1359,"enrollment":1360,"conditions":1361,"interventions":1362},"NCT02299440","Effects of Ketamine in the Acute Phase of Suicidal Ideation",[89],"2019-11-21","2015-04",156,[200],[1344,1363,1364,1365],"1st perfusion of saline","2nd perfusion of ketamine","2nd perfusion of saline",{"trials":1367,"activeCount":99},[],{"trials":1369,"activeCount":99},[],{"intervention":1363,"totalTrials":95,"cells":1371},{"EARLY_PHASE1":1372,"PHASE1":1374,"PHASE2":1376,"PHASE3":1378,"PHASE4":1384,"NA":1386},{"trials":1373,"activeCount":99},[],{"trials":1375,"activeCount":99},[],{"trials":1377,"activeCount":99},[],{"trials":1379,"activeCount":99},[1380],{"nctId":1355,"briefTitle":1356,"status":664,"phases":1381,"primaryCompletion":1358,"completion":1358,"start":1359,"enrollment":1360,"conditions":1382,"interventions":1383},[89],[200],[1344,1363,1364,1365],{"trials":1385,"activeCount":99},[],{"trials":1387,"activeCount":99},[],{"intervention":1364,"totalTrials":95,"cells":1389},{"EARLY_PHASE1":1390,"PHASE1":1392,"PHASE2":1394,"PHASE3":1396,"PHASE4":1402,"NA":1404},{"trials":1391,"activeCount":99},[],{"trials":1393,"activeCount":99},[],{"trials":1395,"activeCount":99},[],{"trials":1397,"activeCount":99},[1398],{"nctId":1355,"briefTitle":1356,"status":664,"phases":1399,"primaryCompletion":1358,"completion":1358,"start":1359,"enrollment":1360,"conditions":1400,"interventions":1401},[89],[200],[1344,1363,1364,1365],{"trials":1403,"activeCount":99},[],{"trials":1405,"activeCount":99},[],{"intervention":1365,"totalTrials":95,"cells":1407},{"EARLY_PHASE1":1408,"PHASE1":1410,"PHASE2":1412,"PHASE3":1414,"PHASE4":1420,"NA":1422},{"trials":1409,"activeCount":99},[],{"trials":1411,"activeCount":99},[],{"trials":1413,"activeCount":99},[],{"trials":1415,"activeCount":99},[1416],{"nctId":1355,"briefTitle":1356,"status":664,"phases":1417,"primaryCompletion":1358,"completion":1358,"start":1359,"enrollment":1360,"conditions":1418,"interventions":1419},[89],[200],[1344,1363,1364,1365],{"trials":1421,"activeCount":99},[],{"trials":1423,"activeCount":99},[],{"intervention":1425,"totalTrials":95,"cells":1426},"Continuous perfusion of esmolol",{"EARLY_PHASE1":1427,"PHASE1":1429,"PHASE2":1431,"PHASE3":1433,"PHASE4":1446,"NA":1448},{"trials":1428,"activeCount":99},[],{"trials":1430,"activeCount":99},[],{"trials":1432,"activeCount":99},[],{"trials":1434,"activeCount":99},[1435],{"nctId":1436,"briefTitle":1437,"status":690,"phases":1438,"primaryCompletion":1439,"completion":1440,"start":1441,"enrollment":99,"conditions":1442,"interventions":1444},"NCT02609152","Effect of a Continuous Infusion of Esmolol on Stroke Volume in Patients With Hyperdynamic Vasoplegic Septic Shock",[89],"2017-07","2017-08","2016-07",[1443],"Shock, Septic",[1425,1445],"Continuous perfusion of saline",{"trials":1447,"activeCount":99},[],{"trials":1449,"activeCount":99},[],{"intervention":1445,"totalTrials":95,"cells":1451},{"EARLY_PHASE1":1452,"PHASE1":1454,"PHASE2":1456,"PHASE3":1458,"PHASE4":1464,"NA":1466},{"trials":1453,"activeCount":99},[],{"trials":1455,"activeCount":99},[],{"trials":1457,"activeCount":99},[],{"trials":1459,"activeCount":99},[1460],{"nctId":1436,"briefTitle":1437,"status":690,"phases":1461,"primaryCompletion":1439,"completion":1440,"start":1441,"enrollment":99,"conditions":1462,"interventions":1463},[89],[1443],[1425,1445],{"trials":1465,"activeCount":99},[],{"trials":1467,"activeCount":99},[],{"intervention":1469,"totalTrials":95,"cells":1470},"56 days of weight-adjusted L-Carnitine treatment",{"EARLY_PHASE1":1471,"PHASE1":1473,"PHASE2":1475,"PHASE3":1477,"PHASE4":1490,"NA":1492},{"trials":1472,"activeCount":99},[],{"trials":1474,"activeCount":99},[],{"trials":1476,"activeCount":99},[],{"trials":1478,"activeCount":99},[1479],{"nctId":1480,"briefTitle":1481,"status":1202,"phases":1482,"primaryCompletion":1483,"completion":1483,"start":1484,"enrollment":1485,"conditions":1486,"interventions":1488},"NCT02664753","L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury",[89],"2024-12-04","2018-03-05",254,[1487,1443,262],"Severe Sepsis",[1469,1489],"10 days of intravenous placebo",{"trials":1491,"activeCount":99},[],{"trials":1493,"activeCount":99},[],{"intervention":1489,"totalTrials":95,"cells":1495},{"EARLY_PHASE1":1496,"PHASE1":1498,"PHASE2":1500,"PHASE3":1502,"PHASE4":1508,"NA":1510},{"trials":1497,"activeCount":99},[],{"trials":1499,"activeCount":99},[],{"trials":1501,"activeCount":99},[],{"trials":1503,"activeCount":99},[1504],{"nctId":1480,"briefTitle":1481,"status":1202,"phases":1505,"primaryCompletion":1483,"completion":1483,"start":1484,"enrollment":1485,"conditions":1506,"interventions":1507},[89],[1487,1443,262],[1469,1489],{"trials":1509,"activeCount":99},[],{"trials":1511,"activeCount":99},[],{"intervention":1513,"totalTrials":95,"cells":1514},"1.0 MIU IL-2 per day",{"EARLY_PHASE1":1515,"PHASE1":1517,"PHASE2":1519,"PHASE3":1532,"PHASE4":1534,"NA":1536},{"trials":1516,"activeCount":99},[],{"trials":1518,"activeCount":99},[],{"trials":1520,"activeCount":99},[1521],{"nctId":1522,"briefTitle":1523,"status":664,"phases":1524,"primaryCompletion":1525,"completion":1525,"start":1526,"enrollment":1527,"conditions":1528,"interventions":1530},"NCT02059759","Immuno-modulation in Amyotrophic Lateral Sclerosis- a Phase II Study of Safety and Activity of Low Dose Interleukin-2",[88],"2016-05-25","2015-09",36,[1529],"Amyotrophic Lateral Sclerosis",[1513,1531],"2.0 MIU IL-2 per day",{"trials":1533,"activeCount":99},[],{"trials":1535,"activeCount":99},[],{"trials":1537,"activeCount":99},[],{"intervention":1531,"totalTrials":95,"cells":1539},{"EARLY_PHASE1":1540,"PHASE1":1542,"PHASE2":1544,"PHASE3":1550,"PHASE4":1552,"NA":1554},{"trials":1541,"activeCount":99},[],{"trials":1543,"activeCount":99},[],{"trials":1545,"activeCount":99},[1546],{"nctId":1522,"briefTitle":1523,"status":664,"phases":1547,"primaryCompletion":1525,"completion":1525,"start":1526,"enrollment":1527,"conditions":1548,"interventions":1549},[88],[1529],[1513,1531],{"trials":1551,"activeCount":99},[],{"trials":1553,"activeCount":99},[],{"trials":1555,"activeCount":99},[],{"intervention":1557,"totalTrials":95,"cells":1558},"Riluzole",{"EARLY_PHASE1":1559,"PHASE1":1561,"PHASE2":1563,"PHASE3":1576,"PHASE4":1578,"NA":1580},{"trials":1560,"activeCount":99},[],{"trials":1562,"activeCount":99},[],{"trials":1564,"activeCount":99},[1565],{"nctId":1566,"briefTitle":1567,"status":664,"phases":1568,"primaryCompletion":1569,"completion":1569,"start":1570,"enrollment":1571,"conditions":1572,"interventions":1573},"NCT03039673","MIROCALS: Modifying Immune Response and OutComes in ALS",[88],"2021-07-22","2017-06-19",304,[1529],[1557,1574,1575],"IL-2","5% glucose water solution",{"trials":1577,"activeCount":99},[],{"trials":1579,"activeCount":99},[],{"trials":1581,"activeCount":99},[],{"intervention":1574,"totalTrials":95,"cells":1583},{"EARLY_PHASE1":1584,"PHASE1":1586,"PHASE2":1588,"PHASE3":1594,"PHASE4":1596,"NA":1598},{"trials":1585,"activeCount":99},[],{"trials":1587,"activeCount":99},[],{"trials":1589,"activeCount":99},[1590],{"nctId":1566,"briefTitle":1567,"status":664,"phases":1591,"primaryCompletion":1569,"completion":1569,"start":1570,"enrollment":1571,"conditions":1592,"interventions":1593},[88],[1529],[1557,1574,1575],{"trials":1595,"activeCount":99},[],{"trials":1597,"activeCount":99},[],{"trials":1599,"activeCount":99},[],{"intervention":1575,"totalTrials":95,"cells":1601},{"EARLY_PHASE1":1602,"PHASE1":1604,"PHASE2":1606,"PHASE3":1612,"PHASE4":1614,"NA":1616},{"trials":1603,"activeCount":99},[],{"trials":1605,"activeCount":99},[],{"trials":1607,"activeCount":99},[1608],{"nctId":1566,"briefTitle":1567,"status":664,"phases":1609,"primaryCompletion":1569,"completion":1569,"start":1570,"enrollment":1571,"conditions":1610,"interventions":1611},[88],[1529],[1557,1574,1575],{"trials":1613,"activeCount":99},[],{"trials":1615,"activeCount":99},[],{"trials":1617,"activeCount":99},[],{"intervention":1619,"totalTrials":95,"cells":1620},"Injection of corticosteroids",{"EARLY_PHASE1":1621,"PHASE1":1623,"PHASE2":1635,"PHASE3":1637,"PHASE4":1639,"NA":1641},{"trials":1622,"activeCount":99},[],{"trials":1624,"activeCount":99},[1625],{"nctId":1626,"briefTitle":1627,"status":664,"phases":1628,"primaryCompletion":1629,"completion":1629,"start":1630,"enrollment":1631,"conditions":1632,"interventions":1634},"NCT05235854","Six-month Performance of Meniscal Wall Infiltration Under Ultrasound to Treat Stable Degenerative Meniscal Injuries.",[87],"2026-05-04","2022-05-12",70,[1633],"Osteoarthritis, Knee",[1619],{"trials":1636,"activeCount":99},[],{"trials":1638,"activeCount":99},[],{"trials":1640,"activeCount":99},[],{"trials":1642,"activeCount":99},[],{"intervention":1644,"totalTrials":95,"cells":1645},"Ambulatory surgery under Lidocaine alone",{"EARLY_PHASE1":1646,"PHASE1":1648,"PHASE2":1663,"PHASE3":1665,"PHASE4":1667,"NA":1669},{"trials":1647,"activeCount":99},[],{"trials":1649,"activeCount":99},[1650],{"nctId":1651,"briefTitle":1652,"status":664,"phases":1653,"primaryCompletion":1654,"completion":1655,"start":1656,"enrollment":1657,"conditions":1658,"interventions":1661},"NCT05343299","Postoperative Experience of 2 WALANT-type Modes of Anesthesia Used in Ambulatory Surgery of the Upper Limb.",[87],"2023-06-25","2023-09-25","2022-05-30",91,[116,117,1659,1660],"Wrist Surgery","Elbow Surgery",[1644,1662],"Ambulatory surgery under a combination of Lidocaine and Ropivacaine",{"trials":1664,"activeCount":99},[],{"trials":1666,"activeCount":99},[],{"trials":1668,"activeCount":99},[],{"trials":1670,"activeCount":99},[],{"intervention":1662,"totalTrials":95,"cells":1672},{"EARLY_PHASE1":1673,"PHASE1":1675,"PHASE2":1681,"PHASE3":1683,"PHASE4":1685,"NA":1687},{"trials":1674,"activeCount":99},[],{"trials":1676,"activeCount":99},[1677],{"nctId":1651,"briefTitle":1652,"status":664,"phases":1678,"primaryCompletion":1654,"completion":1655,"start":1656,"enrollment":1657,"conditions":1679,"interventions":1680},[87],[116,117,1659,1660],[1644,1662],{"trials":1682,"activeCount":99},[],{"trials":1684,"activeCount":99},[],{"trials":1686,"activeCount":99},[],{"trials":1688,"activeCount":99},[],{"intervention":1690,"totalTrials":95,"cells":1691},"anti-SARS-Cov-2 vaccination",{"EARLY_PHASE1":1692,"PHASE1":1704,"PHASE2":1706,"PHASE3":1708,"PHASE4":1710,"NA":1712},{"trials":1693,"activeCount":99},[1694],{"nctId":1695,"briefTitle":1696,"status":664,"phases":1697,"primaryCompletion":1698,"completion":1698,"start":1699,"enrollment":1700,"conditions":1701,"interventions":1703},"NCT05655351","Effect of a Vaccination Against COVID-19 on Monocyte Production of Oxygenated Derivatives.",[86],"2024-07-30","2022-12-21",30,[1702],"CORONAVIRUS INFECTIONS",[1690],{"trials":1705,"activeCount":99},[],{"trials":1707,"activeCount":99},[],{"trials":1709,"activeCount":99},[],{"trials":1711,"activeCount":99},[],{"trials":1713,"activeCount":99},[],{"intervention":1319,"totalTrials":1715,"cells":1716},4,{"EARLY_PHASE1":1717,"PHASE1":1729,"PHASE2":1731,"PHASE3":1733,"PHASE4":1739,"NA":1741},{"trials":1718,"activeCount":99},[1719],{"nctId":1720,"briefTitle":1721,"status":664,"phases":1722,"primaryCompletion":1723,"completion":1723,"start":1724,"enrollment":1725,"conditions":1726,"interventions":1728},"NCT04742374","Effects of Single Plasma Exchange and Double Filtration Plasmapheresis (DFPP) on Peripheral Lymphocyte Phenotypes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy",[86],"2023-12-18","2021-03-12",8,[1727],"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",[1319],{"trials":1730,"activeCount":99},[],{"trials":1732,"activeCount":99},[],{"trials":1734,"activeCount":99},[1735],{"nctId":1310,"briefTitle":1311,"status":664,"phases":1736,"primaryCompletion":1313,"completion":1313,"start":1314,"enrollment":1315,"conditions":1737,"interventions":1738},[89],[15],[1318,1299,1319,1320],{"trials":1740,"activeCount":99},[],{"trials":1742,"activeCount":99},[1743,1755],{"nctId":1744,"briefTitle":1745,"status":664,"phases":1746,"primaryCompletion":1747,"completion":1748,"start":1749,"enrollment":1750,"conditions":1751,"interventions":1754},"NCT02713581","IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism",[],"2019-01-03","2020-06-23","2017-01-03",34,[1752,1753],"Venous Thromboembolism","Pulmonary Embolism",[1319],{"nctId":1756,"briefTitle":1757,"status":664,"phases":1758,"primaryCompletion":1759,"completion":1759,"start":1760,"enrollment":1761,"conditions":1762,"interventions":1764},"NCT01543334","Antibiotic Concentrations Among Critically Ill Patients",[],"2012-04-01","2012-03",98,[1763],"Administration of Antibiotics in Intensive Care Units",[1319],{"intervention":1766,"totalTrials":1767,"cells":1768},"Blood test",3,{"EARLY_PHASE1":1769,"PHASE1":1771,"PHASE2":1773,"PHASE3":1775,"PHASE4":1790,"NA":1792},{"trials":1770,"activeCount":99},[],{"trials":1772,"activeCount":99},[],{"trials":1774,"activeCount":99},[],{"trials":1776,"activeCount":99},[1777],{"nctId":1778,"briefTitle":1779,"status":664,"phases":1780,"primaryCompletion":1781,"completion":1782,"start":1783,"enrollment":1784,"conditions":1785,"interventions":1789},"NCT03634124","Generation of Thrombin and Prediction of Deep Vein Thrombosis Post Prosthetic Orthopedic Surgery of the Lower Limbs",[89],"2023-02-20","2023-10-17","2019-02-21",146,[1786,1787,1788],"Deep Vein Thrombosis","Total Hip Prosthesis","Knee Prosthesis",[1766],{"trials":1791,"activeCount":99},[],{"trials":1793,"activeCount":99},[1794,1804],{"nctId":1795,"briefTitle":1796,"status":1797,"phases":1798,"primaryCompletion":1799,"completion":1799,"start":1800,"enrollment":1801,"conditions":1802,"interventions":1803},"NCT04613791","Situation and Evolution of the Misuse of Alcohol and Other Addictive Behaviors in Obese Patients Being Managed at Nîmes University Hospital","UNKNOWN",[],"2023-12-15","2021-02-16",800,[789],[1766],{"nctId":1805,"briefTitle":1806,"status":664,"phases":1807,"primaryCompletion":1808,"completion":1808,"start":1809,"enrollment":1810,"conditions":1811,"interventions":1812},"NCT04566029","Evolution of Proteomic Profiles of Intestinal Microbiota in Patients With Locally Advanced or Metastatic Urothelial Carcinomas",[],"2022-11-29","2020-12-12",40,[329],[1766,1813],"Stool sample",{"intervention":1813,"totalTrials":1815,"cells":1816},2,{"EARLY_PHASE1":1817,"PHASE1":1819,"PHASE2":1821,"PHASE3":1823,"PHASE4":1825,"NA":1827},{"trials":1818,"activeCount":99},[],{"trials":1820,"activeCount":99},[],{"trials":1822,"activeCount":99},[],{"trials":1824,"activeCount":99},[],{"trials":1826,"activeCount":99},[],{"trials":1828,"activeCount":99},[1829,1842],{"nctId":1830,"briefTitle":1831,"status":664,"phases":1832,"primaryCompletion":1833,"completion":1833,"start":1834,"enrollment":1835,"conditions":1836,"interventions":1838},"NCT02055729","Changes in Bacterial Flora Among Patients With Pelvic Bedsores: a Prospective Pilot Study",[],"2017-09-21","2015-05-11",55,[1837],"Bedsore",[1839,1840,1813,1841],"3mm tissue punch biopsy","Superficial bedsore sample","Urine sample",{"nctId":1805,"briefTitle":1806,"status":664,"phases":1843,"primaryCompletion":1808,"completion":1808,"start":1809,"enrollment":1810,"conditions":1844,"interventions":1845},[],[329],[1766,1813],{"intervention":1318,"totalTrials":1815,"cells":1847},{"EARLY_PHASE1":1848,"PHASE1":1850,"PHASE2":1852,"PHASE3":1854,"PHASE4":1860,"NA":1862},{"trials":1849,"activeCount":99},[],{"trials":1851,"activeCount":99},[],{"trials":1853,"activeCount":99},[],{"trials":1855,"activeCount":99},[1856],{"nctId":1310,"briefTitle":1311,"status":664,"phases":1857,"primaryCompletion":1313,"completion":1313,"start":1314,"enrollment":1315,"conditions":1858,"interventions":1859},[89],[15],[1318,1299,1319,1320],{"trials":1861,"activeCount":99},[],{"trials":1863,"activeCount":99},[1864],{"nctId":1865,"briefTitle":1866,"status":664,"phases":1867,"primaryCompletion":1868,"completion":1868,"start":1869,"enrollment":1870,"conditions":1871,"interventions":1873},"NCT05654818","Peripheral Immunological Effects of High-dose Vitamin D Treatment in Healthy Subjects",[91],"2023-10-10","2023-04-13",56,[1872],"Vitamin d Deficiency",[1318],{"intervention":1875,"totalTrials":1815,"cells":1876},"Psilocybin",{"EARLY_PHASE1":1877,"PHASE1":1879,"PHASE2":1881,"PHASE3":1883,"PHASE4":1885,"NA":1887},{"trials":1878,"activeCount":99},[],{"trials":1880,"activeCount":99},[],{"trials":1882,"activeCount":99},[],{"trials":1884,"activeCount":99},[],{"trials":1886,"activeCount":99},[],{"trials":1888,"activeCount":99},[1889,1902],{"nctId":1890,"briefTitle":1891,"status":664,"phases":1892,"primaryCompletion":1893,"completion":1894,"start":1895,"enrollment":22,"conditions":1896,"interventions":1901},"NCT06650800","Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression",[91],"2025-03-26","2025-06-26","2024-11-19",[1897,1898,1899,1900],"Depressive Disorder","Depressive Disorder, Treatment-Resistant","Hallucinogens","Reinforcement, Psychology",[1875],{"nctId":1903,"briefTitle":1904,"status":664,"phases":1905,"primaryCompletion":1906,"completion":1907,"start":1908,"enrollment":1715,"conditions":1909,"interventions":1911},"NCT06647056","Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients With Psychogenic Nonepileptic Seizures",[91],"2025-01-03","2025-05-22","2024-12-19",[1910,1875],"Psychogenic Nonepileptic Seizures",[1875],{"intervention":1913,"totalTrials":95,"cells":1914},"Vaginal fibronectin measurement",{"EARLY_PHASE1":1915,"PHASE1":1917,"PHASE2":1919,"PHASE3":1921,"PHASE4":1923,"NA":1925},{"trials":1916,"activeCount":99},[],{"trials":1918,"activeCount":99},[],{"trials":1920,"activeCount":99},[],{"trials":1922,"activeCount":99},[],{"trials":1924,"activeCount":99},[],{"trials":1926,"activeCount":99},[1927],{"nctId":1928,"briefTitle":1929,"status":1202,"phases":1930,"primaryCompletion":1931,"completion":1931,"start":1932,"enrollment":1933,"conditions":1934,"interventions":1938},"NCT02021539","The Prognostic Value of Cervical Elastography for Identifying Patients at Risk for Preterm Delivery",[],"2016-12","2014-02",66,[1935,1936,1937],"Obstetric Labor","Labor Onset","Obstetric Labor, Premature",[1913,1939],"Tocolytic treatment for 2 hours",{"intervention":1939,"totalTrials":95,"cells":1941},{"EARLY_PHASE1":1942,"PHASE1":1944,"PHASE2":1946,"PHASE3":1948,"PHASE4":1950,"NA":1952},{"trials":1943,"activeCount":99},[],{"trials":1945,"activeCount":99},[],{"trials":1947,"activeCount":99},[],{"trials":1949,"activeCount":99},[],{"trials":1951,"activeCount":99},[],{"trials":1953,"activeCount":99},[1954],{"nctId":1928,"briefTitle":1929,"status":1202,"phases":1955,"primaryCompletion":1931,"completion":1931,"start":1932,"enrollment":1933,"conditions":1956,"interventions":1957},[],[1935,1936,1937],[1913,1939],{"intervention":1959,"totalTrials":95,"cells":1960},"Tests for candidiasis",{"EARLY_PHASE1":1961,"PHASE1":1963,"PHASE2":1965,"PHASE3":1967,"PHASE4":1969,"NA":1971},{"trials":1962,"activeCount":99},[],{"trials":1964,"activeCount":99},[],{"trials":1966,"activeCount":99},[],{"trials":1968,"activeCount":99},[],{"trials":1970,"activeCount":99},[],{"trials":1972,"activeCount":99},[1973],{"nctId":1974,"briefTitle":1975,"status":664,"phases":1976,"primaryCompletion":1977,"completion":1977,"start":1978,"enrollment":1979,"conditions":1980,"interventions":1982},"NCT01322698","Staging Candidiasis in ICU Patients",[],"2014-10-07","2011-10",422,[1981],"Candidiasis",[1959],{"intervention":1984,"totalTrials":95,"cells":1985},"Rivaroxaban",{"EARLY_PHASE1":1986,"PHASE1":1988,"PHASE2":1990,"PHASE3":1992,"PHASE4":1994,"NA":1996},{"trials":1987,"activeCount":99},[],{"trials":1989,"activeCount":99},[],{"trials":1991,"activeCount":99},[],{"trials":1993,"activeCount":99},[],{"trials":1995,"activeCount":99},[],{"trials":1997,"activeCount":99},[1998],{"nctId":1999,"briefTitle":2000,"status":664,"phases":2001,"primaryCompletion":2002,"completion":2002,"start":2003,"enrollment":2004,"conditions":2005,"interventions":2007},"NCT02273700","Plasma Modifications Associated With Rivaroxaban® Treatment for Stroke Prevention",[],"2016-01","2015-11",5,[2006],"Atrial Fibrillation",[1984],{"intervention":2009,"totalTrials":95,"cells":2010},"Phenotyping of total and innate CD8+T cells by flow cytometry",{"EARLY_PHASE1":2011,"PHASE1":2013,"PHASE2":2015,"PHASE3":2017,"PHASE4":2019,"NA":2021},{"trials":2012,"activeCount":99},[],{"trials":2014,"activeCount":99},[],{"trials":2016,"activeCount":99},[],{"trials":2018,"activeCount":99},[],{"trials":2020,"activeCount":99},[],{"trials":2022,"activeCount":99},[2023],{"nctId":2024,"briefTitle":2025,"status":1797,"phases":2026,"primaryCompletion":2027,"completion":38,"start":2028,"enrollment":1700,"conditions":2029,"interventions":2034},"NCT04965649","Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies.",[],"2024-07-01","2021-01-01",[2030,2031,2032,2033],"Leukemia","Myelogenous Leukemia","Chronic Leukemia","BCR-ABL Positive Acute Myeloid Leukemia",[2009],{"intervention":2036,"totalTrials":95,"cells":2037},"Serum concentration of lithium or sodium divalproate.",{"EARLY_PHASE1":2038,"PHASE1":2040,"PHASE2":2042,"PHASE3":2044,"PHASE4":2046,"NA":2048},{"trials":2039,"activeCount":99},[],{"trials":2041,"activeCount":99},[],{"trials":2043,"activeCount":99},[],{"trials":2045,"activeCount":99},[],{"trials":2047,"activeCount":99},[],{"trials":2049,"activeCount":99},[2050],{"nctId":2051,"briefTitle":2052,"status":690,"phases":2053,"primaryCompletion":2054,"completion":2054,"start":2055,"enrollment":99,"conditions":2056,"interventions":2058},"NCT02116400","Neuropsychological Characterization of Patients With Bipolar Disorder and a History of Suicide Attempt",[],"2018-07","2017-01",[2057],"Bipolar Disorder",[2036],{"intervention":2060,"totalTrials":95,"cells":2061},"Anti-IL-17 therapy",{"EARLY_PHASE1":2062,"PHASE1":2064,"PHASE2":2066,"PHASE3":2068,"PHASE4":2070,"NA":2072},{"trials":2063,"activeCount":99},[],{"trials":2065,"activeCount":99},[],{"trials":2067,"activeCount":99},[],{"trials":2069,"activeCount":99},[],{"trials":2071,"activeCount":99},[],{"trials":2073,"activeCount":99},[2074],{"nctId":2075,"briefTitle":2076,"status":664,"phases":2077,"primaryCompletion":2078,"completion":2078,"start":2079,"enrollment":2080,"conditions":2081,"interventions":2083},"NCT05812157","Optimizing Anti-IL17 Antibody Therapy by Associating Fiber Supplementation to Correct Treatment-aggravated Gut Dysbiosis in Axial Spondyloarthritis - RESPOND-IL17",[91],"2026-02-23","2023-10-02",76,[2082],"Axial Spondyloarthritis",[2060],{"intervention":2085,"totalTrials":95,"cells":2086},"EPISPOT detection of the number of circulating cells",{"EARLY_PHASE1":2087,"PHASE1":2089,"PHASE2":2091,"PHASE3":2093,"PHASE4":2095,"NA":2097},{"trials":2088,"activeCount":99},[],{"trials":2090,"activeCount":99},[],{"trials":2092,"activeCount":99},[],{"trials":2094,"activeCount":99},[],{"trials":2096,"activeCount":99},[],{"trials":2098,"activeCount":99},[2099],{"nctId":2100,"briefTitle":2101,"status":1797,"phases":2102,"primaryCompletion":2103,"completion":2104,"start":2105,"enrollment":2106,"conditions":2107,"interventions":2109},"NCT01402154","EPISPOT Detection of Circulating Prostate Cells Among Adenocarcinoma Patients",[],"2014-12-08","2021-12","2012-01-03",361,[2108],"Adenocarcinoma of the Prostate",[2085,2110],"CellSearch detection of the number of circulating, functional, prostate cells",{"intervention":2110,"totalTrials":95,"cells":2112},{"EARLY_PHASE1":2113,"PHASE1":2115,"PHASE2":2117,"PHASE3":2119,"PHASE4":2121,"NA":2123},{"trials":2114,"activeCount":99},[],{"trials":2116,"activeCount":99},[],{"trials":2118,"activeCount":99},[],{"trials":2120,"activeCount":99},[],{"trials":2122,"activeCount":99},[],{"trials":2124,"activeCount":99},[2125],{"nctId":2100,"briefTitle":2101,"status":1797,"phases":2126,"primaryCompletion":2103,"completion":2104,"start":2105,"enrollment":2106,"conditions":2127,"interventions":2128},[],[2108],[2085,2110],{"intervention":2130,"totalTrials":95,"cells":2131},"Samples and follow up",{"EARLY_PHASE1":2132,"PHASE1":2134,"PHASE2":2136,"PHASE3":2138,"PHASE4":2140,"NA":2142},{"trials":2133,"activeCount":99},[],{"trials":2135,"activeCount":99},[],{"trials":2137,"activeCount":99},[],{"trials":2139,"activeCount":99},[],{"trials":2141,"activeCount":99},[],{"trials":2143,"activeCount":99},[2144],{"nctId":2145,"briefTitle":2146,"status":664,"phases":2147,"primaryCompletion":760,"completion":760,"start":2148,"enrollment":286,"conditions":2149,"interventions":2151},"NCT01577511","Invasiveness and Chemoresistance of Cancer Stem Cells in Colon Cancer",[],"2012-06-12",[2150],"Colorectal Neoplasms",[2130],{"intervention":2153,"totalTrials":95,"cells":2154},"Routine biological analyses",{"EARLY_PHASE1":2155,"PHASE1":2157,"PHASE2":2159,"PHASE3":2161,"PHASE4":2163,"NA":2165},{"trials":2156,"activeCount":99},[],{"trials":2158,"activeCount":99},[],{"trials":2160,"activeCount":99},[],{"trials":2162,"activeCount":99},[],{"trials":2164,"activeCount":99},[],{"trials":2166,"activeCount":99},[2167],{"nctId":2168,"briefTitle":2169,"status":664,"phases":2170,"primaryCompletion":2171,"completion":2171,"start":2172,"enrollment":2173,"conditions":2174,"interventions":2175},"NCT01231672","Prospective Validation of Clini-biological Parameters Including Initial Hemostasis, Which Improve the Prediction of Death at 1 Month Among Patients With Septic Shock",[],"2013-10-30","2009-04",780,[1443],[2153],{"intervention":2177,"totalTrials":95,"cells":2178},"Blood drawn for genotyping",{"EARLY_PHASE1":2179,"PHASE1":2181,"PHASE2":2183,"PHASE3":2185,"PHASE4":2187,"NA":2189},{"trials":2180,"activeCount":99},[],{"trials":2182,"activeCount":99},[],{"trials":2184,"activeCount":99},[],{"trials":2186,"activeCount":99},[],{"trials":2188,"activeCount":99},[],{"trials":2190,"activeCount":99},[2191],{"nctId":2192,"briefTitle":2193,"status":664,"phases":2194,"primaryCompletion":2195,"completion":2195,"start":2196,"enrollment":2197,"conditions":2198,"interventions":2200},"NCT02404584","The Pharmacokinetic Variability of Sunitinib in Patients With Metastatic Renal Cancer",[],"2019-05-21","2015-12-29",43,[2199],"Kidney Neoplasms",[2177,2201],"Blood drawn for pharmacokinetic measures",{"intervention":2201,"totalTrials":95,"cells":2203},{"EARLY_PHASE1":2204,"PHASE1":2206,"PHASE2":2208,"PHASE3":2210,"PHASE4":2212,"NA":2214},{"trials":2205,"activeCount":99},[],{"trials":2207,"activeCount":99},[],{"trials":2209,"activeCount":99},[],{"trials":2211,"activeCount":99},[],{"trials":2213,"activeCount":99},[],{"trials":2215,"activeCount":99},[2216],{"nctId":2192,"briefTitle":2193,"status":664,"phases":2217,"primaryCompletion":2195,"completion":2195,"start":2196,"enrollment":2197,"conditions":2218,"interventions":2219},[],[2199],[2177,2201],{"intervention":1839,"totalTrials":95,"cells":2221},{"EARLY_PHASE1":2222,"PHASE1":2224,"PHASE2":2226,"PHASE3":2228,"PHASE4":2230,"NA":2232},{"trials":2223,"activeCount":99},[],{"trials":2225,"activeCount":99},[],{"trials":2227,"activeCount":99},[],{"trials":2229,"activeCount":99},[],{"trials":2231,"activeCount":99},[],{"trials":2233,"activeCount":99},[2234],{"nctId":1830,"briefTitle":1831,"status":664,"phases":2235,"primaryCompletion":1833,"completion":1833,"start":1834,"enrollment":1835,"conditions":2236,"interventions":2237},[],[1837],[1839,1840,1813,1841],{"intervention":1840,"totalTrials":95,"cells":2239},{"EARLY_PHASE1":2240,"PHASE1":2242,"PHASE2":2244,"PHASE3":2246,"PHASE4":2248,"NA":2250},{"trials":2241,"activeCount":99},[],{"trials":2243,"activeCount":99},[],{"trials":2245,"activeCount":99},[],{"trials":2247,"activeCount":99},[],{"trials":2249,"activeCount":99},[],{"trials":2251,"activeCount":99},[2252],{"nctId":1830,"briefTitle":1831,"status":664,"phases":2253,"primaryCompletion":1833,"completion":1833,"start":1834,"enrollment":1835,"conditions":2254,"interventions":2255},[],[1837],[1839,1840,1813,1841],{"intervention":1841,"totalTrials":95,"cells":2257},{"EARLY_PHASE1":2258,"PHASE1":2260,"PHASE2":2262,"PHASE3":2264,"PHASE4":2266,"NA":2268},{"trials":2259,"activeCount":99},[],{"trials":2261,"activeCount":99},[],{"trials":2263,"activeCount":99},[],{"trials":2265,"activeCount":99},[],{"trials":2267,"activeCount":99},[],{"trials":2269,"activeCount":99},[2270],{"nctId":1830,"briefTitle":1831,"status":664,"phases":2271,"primaryCompletion":1833,"completion":1833,"start":1834,"enrollment":1835,"conditions":2272,"interventions":2273},[],[1837],[1839,1840,1813,1841],{"intervention":2275,"totalTrials":95,"cells":2276},"Metvixia cream",{"EARLY_PHASE1":2277,"PHASE1":2279,"PHASE2":2281,"PHASE3":2283,"PHASE4":2285,"NA":2287},{"trials":2278,"activeCount":99},[],{"trials":2280,"activeCount":99},[],{"trials":2282,"activeCount":99},[],{"trials":2284,"activeCount":99},[],{"trials":2286,"activeCount":99},[],{"trials":2288,"activeCount":99},[2289],{"nctId":2290,"briefTitle":2291,"status":664,"phases":2292,"primaryCompletion":2293,"completion":2293,"start":2294,"enrollment":22,"conditions":2295,"interventions":2297},"NCT02392390","Effects of Topical Dynamic Phototherapy on the Microbiota of Chronic Wounds",[91],"2016-03","2015-10",[2296],"Leg Ulcer",[2275],{"intervention":2299,"totalTrials":95,"cells":2300},"Bloodwork",{"EARLY_PHASE1":2301,"PHASE1":2303,"PHASE2":2305,"PHASE3":2307,"PHASE4":2309,"NA":2311},{"trials":2302,"activeCount":99},[],{"trials":2304,"activeCount":99},[],{"trials":2306,"activeCount":99},[],{"trials":2308,"activeCount":99},[],{"trials":2310,"activeCount":99},[],{"trials":2312,"activeCount":99},[2313],{"nctId":2314,"briefTitle":2315,"status":1202,"phases":2316,"primaryCompletion":761,"completion":761,"start":692,"enrollment":16,"conditions":2317,"interventions":2319},"NCT01322256","PET\u002FCT Scanning for the Follow-up of Antibiotic Treatment of Infectious Osteoarthritis in the Diabetic Foot",[91],[288,2318],"Osteoarthritis",[2299],{"intervention":2321,"totalTrials":95,"cells":2322},"Antiphospholipid antibody tests",{"EARLY_PHASE1":2323,"PHASE1":2325,"PHASE2":2327,"PHASE3":2329,"PHASE4":2331,"NA":2333},{"trials":2324,"activeCount":99},[],{"trials":2326,"activeCount":99},[],{"trials":2328,"activeCount":99},[],{"trials":2330,"activeCount":99},[],{"trials":2332,"activeCount":99},[],{"trials":2334,"activeCount":99},[2335],{"nctId":2336,"briefTitle":2337,"status":1202,"phases":2338,"primaryCompletion":2339,"completion":2339,"start":2340,"enrollment":2341,"conditions":2342,"interventions":2344},"NCT01649479","Comparative Prevalence of Psychiatric Manifestations in Purely Obstetrical Antiphospholipid Syndrome",[91],"2013-09","2013-04",20,[2343],"Antiphospholipid Syndrome",[2321,2345],"Thrombophilia bloodwork",{"intervention":2345,"totalTrials":95,"cells":2347},{"EARLY_PHASE1":2348,"PHASE1":2350,"PHASE2":2352,"PHASE3":2354,"PHASE4":2356,"NA":2358},{"trials":2349,"activeCount":99},[],{"trials":2351,"activeCount":99},[],{"trials":2353,"activeCount":99},[],{"trials":2355,"activeCount":99},[],{"trials":2357,"activeCount":99},[],{"trials":2359,"activeCount":99},[2360],{"nctId":2336,"briefTitle":2337,"status":1202,"phases":2361,"primaryCompletion":2339,"completion":2339,"start":2340,"enrollment":2341,"conditions":2362,"interventions":2363},[91],[2343],[2321,2345],{"intervention":2365,"totalTrials":95,"cells":2366},"Antibody assays for S. aureus",{"EARLY_PHASE1":2367,"PHASE1":2369,"PHASE2":2371,"PHASE3":2373,"PHASE4":2375,"NA":2377},{"trials":2368,"activeCount":99},[],{"trials":2370,"activeCount":99},[],{"trials":2372,"activeCount":99},[],{"trials":2374,"activeCount":99},[],{"trials":2376,"activeCount":99},[],{"trials":2378,"activeCount":99},[2379],{"nctId":2380,"briefTitle":2381,"status":664,"phases":2382,"primaryCompletion":2293,"completion":2293,"start":784,"enrollment":2383,"conditions":2384,"interventions":2388},"NCT01551667","Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds",[],69,[288,2385,2296,2386,2387],"Foot Ulcer","Bacteremia","Infection",[2365,2389],"Basic blood work",{"intervention":2389,"totalTrials":95,"cells":2391},{"EARLY_PHASE1":2392,"PHASE1":2394,"PHASE2":2396,"PHASE3":2398,"PHASE4":2400,"NA":2402},{"trials":2393,"activeCount":99},[],{"trials":2395,"activeCount":99},[],{"trials":2397,"activeCount":99},[],{"trials":2399,"activeCount":99},[],{"trials":2401,"activeCount":99},[],{"trials":2403,"activeCount":99},[2404],{"nctId":2380,"briefTitle":2381,"status":664,"phases":2405,"primaryCompletion":2293,"completion":2293,"start":784,"enrollment":2383,"conditions":2406,"interventions":2407},[],[288,2385,2296,2386,2387],[2365,2389],{"intervention":2409,"totalTrials":95,"cells":2410},"Rocuronium",{"EARLY_PHASE1":2411,"PHASE1":2413,"PHASE2":2415,"PHASE3":2417,"PHASE4":2419,"NA":2421},{"trials":2412,"activeCount":99},[],{"trials":2414,"activeCount":99},[],{"trials":2416,"activeCount":99},[],{"trials":2418,"activeCount":99},[],{"trials":2420,"activeCount":99},[],{"trials":2422,"activeCount":99},[2423],{"nctId":2424,"briefTitle":2425,"status":664,"phases":2426,"primaryCompletion":2427,"completion":2427,"start":2428,"enrollment":2429,"conditions":2430,"interventions":2432},"NCT03545308","Pharmacokinetics of Rocuronium for Deep Block (DeepRocu)",[],"2018-03-01","2017-08-25",250,[2431],"Neuromuscular Blockade",[2409],{"intervention":2434,"totalTrials":95,"cells":2435},"APO E genotyping",{"EARLY_PHASE1":2436,"PHASE1":2438,"PHASE2":2440,"PHASE3":2442,"PHASE4":2444,"NA":2446},{"trials":2437,"activeCount":99},[],{"trials":2439,"activeCount":99},[],{"trials":2441,"activeCount":99},[],{"trials":2443,"activeCount":99},[],{"trials":2445,"activeCount":99},[],{"trials":2447,"activeCount":99},[2448],{"nctId":2449,"briefTitle":2450,"status":690,"phases":2451,"primaryCompletion":2452,"completion":2452,"start":2453,"enrollment":99,"conditions":2454,"interventions":2457},"NCT02664571","Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis",[91],"2021-07","2020-07",[2455,2456],"Amyloid Cerebral Angiopathy","Alzheimer Disease",[2434],{"intervention":2459,"totalTrials":95,"cells":2460},"Blood flow to the tracheo-bronchial mucosa",{"EARLY_PHASE1":2461,"PHASE1":2463,"PHASE2":2465,"PHASE3":2467,"PHASE4":2469,"NA":2471},{"trials":2462,"activeCount":99},[],{"trials":2464,"activeCount":99},[],{"trials":2466,"activeCount":99},[],{"trials":2468,"activeCount":99},[],{"trials":2470,"activeCount":99},[],{"trials":2472,"activeCount":99},[2473],{"nctId":2474,"briefTitle":2475,"status":690,"phases":2476,"primaryCompletion":2477,"completion":2477,"start":2478,"enrollment":99,"conditions":2479,"interventions":2481},"NCT01402752","System for Measuring Non-invasive Blood Flow in the Tracheobronchial Mucosa: Validation of Reproducibility",[91],"2014-03","2013-11",[2480],"Healthy",[2459],{"intervention":2483,"totalTrials":95,"cells":2484},"Plasma NGAL level",{"EARLY_PHASE1":2485,"PHASE1":2487,"PHASE2":2489,"PHASE3":2491,"PHASE4":2493,"NA":2495},{"trials":2486,"activeCount":99},[],{"trials":2488,"activeCount":99},[],{"trials":2490,"activeCount":99},[],{"trials":2492,"activeCount":99},[],{"trials":2494,"activeCount":99},[],{"trials":2496,"activeCount":99},[2497],{"nctId":2498,"briefTitle":2499,"status":664,"phases":2500,"primaryCompletion":2501,"completion":2501,"start":2502,"enrollment":2503,"conditions":2504,"interventions":2507},"NCT01544231","Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis",[],"2015-12-09","2013-08",197,[2505,2506],"Rhabdomyolysis","Acute Kidney Failure",[2483],{"intervention":2509,"totalTrials":95,"cells":2510},"TNF blockers monotherapy",{"EARLY_PHASE1":2511,"PHASE1":2513,"PHASE2":2515,"PHASE3":2517,"PHASE4":2519,"NA":2521},{"trials":2512,"activeCount":99},[],{"trials":2514,"activeCount":99},[],{"trials":2516,"activeCount":99},[],{"trials":2518,"activeCount":99},[],{"trials":2520,"activeCount":99},[],{"trials":2522,"activeCount":99},[2523],{"nctId":2524,"briefTitle":2525,"status":664,"phases":2526,"primaryCompletion":938,"start":2527,"enrollment":2528,"conditions":2529,"interventions":2531},"NCT02927535","Evaluation of TNFα Blockers Monotherapy in Early Rheumatoid Arthritis in France",[],"2015-01",813,[2530],"Rheumatoid Arthritis",[2509],{"intervention":2533,"totalTrials":95,"cells":2534},"Genetic profiling of bacterial cultures",{"EARLY_PHASE1":2535,"PHASE1":2537,"PHASE2":2539,"PHASE3":2541,"PHASE4":2543,"NA":2545},{"trials":2536,"activeCount":99},[],{"trials":2538,"activeCount":99},[],{"trials":2540,"activeCount":99},[],{"trials":2542,"activeCount":99},[],{"trials":2544,"activeCount":99},[],{"trials":2546,"activeCount":99},[2547],{"nctId":2548,"briefTitle":2549,"status":664,"phases":2550,"primaryCompletion":2551,"completion":2551,"start":693,"enrollment":2552,"conditions":2553,"interventions":2555},"NCT01212120","The Foot in Your Nose Study: Links Between Nasal Staphylococcus Aureus Colonies and Diabetic Foot Lesion Infections",[],"2012-03-19",278,[288,2554],"Staphylococcus Aureus",[2533],{"intervention":2557,"totalTrials":95,"cells":2558},"Hysteroscopy + endometrial biopsy",{"EARLY_PHASE1":2559,"PHASE1":2561,"PHASE2":2563,"PHASE3":2565,"PHASE4":2567,"NA":2569},{"trials":2560,"activeCount":99},[],{"trials":2562,"activeCount":99},[],{"trials":2564,"activeCount":99},[],{"trials":2566,"activeCount":99},[],{"trials":2568,"activeCount":99},[],{"trials":2570,"activeCount":99},[2571],{"nctId":2572,"briefTitle":2573,"status":690,"phases":2574,"primaryCompletion":2575,"completion":2576,"start":2003,"enrollment":99,"conditions":2577,"interventions":2581},"NCT02328742","Development of a Bioabsorbable Medical Device for the Prevention of Postoperative Intra-uterine Adhesions.",[],"2017-11","2018-05",[2578,2579,2580],"Infertility","Abortion, Spontaneous","Embryo Implantation, Delayed",[2557,2582,2583],"Resection + endometrial biopsy","Follow-up hysteroscopy + endometrial biopsy",{"intervention":2582,"totalTrials":95,"cells":2585},{"EARLY_PHASE1":2586,"PHASE1":2588,"PHASE2":2590,"PHASE3":2592,"PHASE4":2594,"NA":2596},{"trials":2587,"activeCount":99},[],{"trials":2589,"activeCount":99},[],{"trials":2591,"activeCount":99},[],{"trials":2593,"activeCount":99},[],{"trials":2595,"activeCount":99},[],{"trials":2597,"activeCount":99},[2598],{"nctId":2572,"briefTitle":2573,"status":690,"phases":2599,"primaryCompletion":2575,"completion":2576,"start":2003,"enrollment":99,"conditions":2600,"interventions":2601},[],[2578,2579,2580],[2557,2582,2583],{"intervention":2583,"totalTrials":95,"cells":2603},{"EARLY_PHASE1":2604,"PHASE1":2606,"PHASE2":2608,"PHASE3":2610,"PHASE4":2612,"NA":2614},{"trials":2605,"activeCount":99},[],{"trials":2607,"activeCount":99},[],{"trials":2609,"activeCount":99},[],{"trials":2611,"activeCount":99},[],{"trials":2613,"activeCount":99},[],{"trials":2615,"activeCount":99},[2616],{"nctId":2572,"briefTitle":2573,"status":690,"phases":2617,"primaryCompletion":2575,"completion":2576,"start":2003,"enrollment":99,"conditions":2618,"interventions":2619},[],[2578,2579,2580],[2557,2582,2583],{"intervention":2621,"totalTrials":95,"cells":2622},"SNP (single nucleotide polymorphism) genotyping",{"EARLY_PHASE1":2623,"PHASE1":2625,"PHASE2":2627,"PHASE3":2629,"PHASE4":2631,"NA":2633},{"trials":2624,"activeCount":99},[],{"trials":2626,"activeCount":99},[],{"trials":2628,"activeCount":99},[],{"trials":2630,"activeCount":99},[],{"trials":2632,"activeCount":99},[],{"trials":2634,"activeCount":99},[2635],{"nctId":2636,"briefTitle":2637,"status":664,"phases":2638,"primaryCompletion":2639,"completion":2639,"start":2640,"enrollment":2641,"conditions":2642,"interventions":2646},"NCT04565834","Effect of Genetic Alterations Affecting the Genes Encoding the Major Enzymes of the Kynurenine Pathway on Suicidal Behavior",[],"2023-03-01","2019-12-01",849,[2643,2644,2645],"Tryptophan Metabolism Alterations","Polymorphism","Suicidal Behavior",[2621],{"intervention":2648,"totalTrials":95,"cells":2649},"1 month of PDE5i treatment",{"EARLY_PHASE1":2650,"PHASE1":2652,"PHASE2":2654,"PHASE3":2656,"PHASE4":2658,"NA":2660},{"trials":2651,"activeCount":99},[],{"trials":2653,"activeCount":99},[],{"trials":2655,"activeCount":99},[],{"trials":2657,"activeCount":99},[],{"trials":2659,"activeCount":99},[],{"trials":2661,"activeCount":99},[2662],{"nctId":2663,"briefTitle":2664,"status":664,"phases":2665,"primaryCompletion":2666,"completion":2667,"start":2668,"enrollment":2669,"conditions":2670,"interventions":2672},"NCT02304679","Low Energy Shockwave Therapy for Improving Erectile Dysfunction",[91],"2018-02-21","2020-06-22","2015-07-01",154,[2671],"Erectile Dysfunction",[2648],{"intervention":2674,"totalTrials":95,"cells":2675},"Antibiofilmogramme",{"EARLY_PHASE1":2676,"PHASE1":2678,"PHASE2":2680,"PHASE3":2682,"PHASE4":2684,"NA":2686},{"trials":2677,"activeCount":99},[],{"trials":2679,"activeCount":99},[],{"trials":2681,"activeCount":99},[],{"trials":2683,"activeCount":99},[],{"trials":2685,"activeCount":99},[],{"trials":2687,"activeCount":99},[2688],{"nctId":2689,"briefTitle":2690,"status":664,"phases":2691,"primaryCompletion":2692,"completion":2692,"start":2693,"enrollment":2694,"conditions":2695,"interventions":2696},"NCT02378493","Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections",[91],"2019-07-17","2015-12-16",33,[288,2554],[2674],{"intervention":2698,"totalTrials":95,"cells":2699},"Biological sampling grinding",{"EARLY_PHASE1":2700,"PHASE1":2702,"PHASE2":2704,"PHASE3":2706,"PHASE4":2708,"NA":2710},{"trials":2701,"activeCount":99},[],{"trials":2703,"activeCount":99},[],{"trials":2705,"activeCount":99},[],{"trials":2707,"activeCount":99},[],{"trials":2709,"activeCount":99},[],{"trials":2711,"activeCount":99},[2712],{"nctId":2713,"briefTitle":2714,"status":664,"phases":2715,"primaryCompletion":2716,"completion":2716,"start":2717,"enrollment":2718,"conditions":2719,"interventions":2721},"NCT02598141","Grinding Versus Standard Methods for the Treatment of Per-operative Bacteriological Samples Associated With Osteo-articular Sepsis",[91],"2018-11-21","2016-05-18",122,[2720],"Bacterial Infection",[2698,2722],"Biological sampling with standard procedures",{"intervention":2722,"totalTrials":95,"cells":2724},{"EARLY_PHASE1":2725,"PHASE1":2727,"PHASE2":2729,"PHASE3":2731,"PHASE4":2733,"NA":2735},{"trials":2726,"activeCount":99},[],{"trials":2728,"activeCount":99},[],{"trials":2730,"activeCount":99},[],{"trials":2732,"activeCount":99},[],{"trials":2734,"activeCount":99},[],{"trials":2736,"activeCount":99},[2737],{"nctId":2713,"briefTitle":2714,"status":664,"phases":2738,"primaryCompletion":2716,"completion":2716,"start":2717,"enrollment":2718,"conditions":2739,"interventions":2740},[91],[2720],[2698,2722],{"intervention":2742,"totalTrials":95,"cells":2743},"Bacteriological analysis of vaginal sample",{"EARLY_PHASE1":2744,"PHASE1":2746,"PHASE2":2748,"PHASE3":2750,"PHASE4":2752,"NA":2754},{"trials":2745,"activeCount":99},[],{"trials":2747,"activeCount":99},[],{"trials":2749,"activeCount":99},[],{"trials":2751,"activeCount":99},[],{"trials":2753,"activeCount":99},[],{"trials":2755,"activeCount":99},[2756],{"nctId":2757,"briefTitle":2758,"status":664,"phases":2759,"primaryCompletion":2760,"completion":2760,"start":2761,"enrollment":2762,"conditions":2763,"interventions":2765},"NCT01822782","Abnormal Vaginal Flora and Vaginal Lesions at Delivery: is There a Relationship?",[],"2013-12-06","2013-06",1100,[2764],"Vaginal Lesion",[2742],{"intervention":2767,"totalTrials":95,"cells":2768},"Plasma S100B levels at inclusion",{"EARLY_PHASE1":2769,"PHASE1":2771,"PHASE2":2773,"PHASE3":2775,"PHASE4":2777,"NA":2779},{"trials":2770,"activeCount":99},[],{"trials":2772,"activeCount":99},[],{"trials":2774,"activeCount":99},[],{"trials":2776,"activeCount":99},[],{"trials":2778,"activeCount":99},[],{"trials":2780,"activeCount":99},[2781],{"nctId":2782,"briefTitle":2783,"status":664,"phases":2784,"primaryCompletion":2785,"completion":2785,"start":2786,"enrollment":2787,"conditions":2788,"interventions":2790},"NCT02683304","S100B in the Care of Non-traumatic Headaches in the Emergency Department",[91],"2020-03-20","2017-03-10",81,[2789],"Headache",[2767],{"intervention":2792,"totalTrials":95,"cells":2793},"Saliva sampling",{"EARLY_PHASE1":2794,"PHASE1":2796,"PHASE2":2798,"PHASE3":2800,"PHASE4":2802,"NA":2804},{"trials":2795,"activeCount":99},[],{"trials":2797,"activeCount":99},[],{"trials":2799,"activeCount":99},[],{"trials":2801,"activeCount":99},[],{"trials":2803,"activeCount":99},[],{"trials":2805,"activeCount":99},[2806],{"nctId":2807,"briefTitle":2808,"status":664,"phases":2809,"primaryCompletion":2810,"completion":2810,"start":2811,"enrollment":1870,"conditions":2812,"interventions":2814},"NCT02056262","Pathogenic Species and Genotypes of Bacterial Diversity in Relation to the Severity of Dental Caries",[],"2017-03-08","2016-03-15",[2813],"Dental Cavity",[2792,2815],"Plaque sampling",{"intervention":2815,"totalTrials":95,"cells":2817},{"EARLY_PHASE1":2818,"PHASE1":2820,"PHASE2":2822,"PHASE3":2824,"PHASE4":2826,"NA":2828},{"trials":2819,"activeCount":99},[],{"trials":2821,"activeCount":99},[],{"trials":2823,"activeCount":99},[],{"trials":2825,"activeCount":99},[],{"trials":2827,"activeCount":99},[],{"trials":2829,"activeCount":99},[2830],{"nctId":2807,"briefTitle":2808,"status":664,"phases":2831,"primaryCompletion":2810,"completion":2810,"start":2811,"enrollment":1870,"conditions":2832,"interventions":2833},[],[2813],[2792,2815],{"intervention":2835,"totalTrials":95,"cells":2836},"Steroid Drug",{"EARLY_PHASE1":2837,"PHASE1":2839,"PHASE2":2841,"PHASE3":2843,"PHASE4":2845,"NA":2847},{"trials":2838,"activeCount":99},[],{"trials":2840,"activeCount":99},[],{"trials":2842,"activeCount":99},[],{"trials":2844,"activeCount":99},[],{"trials":2846,"activeCount":99},[],{"trials":2848,"activeCount":99},[2849],{"nctId":2850,"briefTitle":2851,"status":664,"phases":2852,"primaryCompletion":2853,"completion":2853,"start":2854,"enrollment":2429,"conditions":2855,"interventions":2857},"NCT03390179","Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)",[],"2018-02-28","2017-09-04",[2856,2480],"Diabetes",[2835],{"intervention":2859,"totalTrials":95,"cells":2860},"Plasma analysis for bacterial translocation",{"EARLY_PHASE1":2861,"PHASE1":2863,"PHASE2":2865,"PHASE3":2867,"PHASE4":2869,"NA":2871},{"trials":2862,"activeCount":99},[],{"trials":2864,"activeCount":99},[],{"trials":2866,"activeCount":99},[],{"trials":2868,"activeCount":99},[],{"trials":2870,"activeCount":99},[],{"trials":2872,"activeCount":99},[2873],{"nctId":2874,"briefTitle":2875,"status":664,"phases":2876,"primaryCompletion":2877,"completion":2877,"start":2878,"enrollment":1835,"conditions":2879,"interventions":2881},"NCT01961310","Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With Rheumatoid Arthritis",[],"2018-03-29","2016-03-08",[2880],"Arthritis, Rheumatoid",[2859,2882],"Stool analysis",{"intervention":2882,"totalTrials":95,"cells":2884},{"EARLY_PHASE1":2885,"PHASE1":2887,"PHASE2":2889,"PHASE3":2891,"PHASE4":2893,"NA":2895},{"trials":2886,"activeCount":99},[],{"trials":2888,"activeCount":99},[],{"trials":2890,"activeCount":99},[],{"trials":2892,"activeCount":99},[],{"trials":2894,"activeCount":99},[],{"trials":2896,"activeCount":99},[2897],{"nctId":2874,"briefTitle":2875,"status":664,"phases":2898,"primaryCompletion":2877,"completion":2877,"start":2878,"enrollment":1835,"conditions":2899,"interventions":2900},[],[2880],[2859,2882],{"intervention":2902,"totalTrials":95,"cells":2903},"Whole blood sampling",{"EARLY_PHASE1":2904,"PHASE1":2906,"PHASE2":2908,"PHASE3":2910,"PHASE4":2912,"NA":2914},{"trials":2905,"activeCount":99},[],{"trials":2907,"activeCount":99},[],{"trials":2909,"activeCount":99},[],{"trials":2911,"activeCount":99},[],{"trials":2913,"activeCount":99},[],{"trials":2915,"activeCount":99},[2916],{"nctId":2917,"briefTitle":2918,"status":1202,"phases":2919,"primaryCompletion":2920,"completion":2920,"start":2921,"enrollment":2922,"conditions":2923,"interventions":2926},"NCT01107158","LXRs, Cholesterol Metabolism and Uterine Dystocia",[],"2015-09-03","2010-04",58,[2924,2925],"Uterine Inertia","Dystocia",[2902],{"intervention":2928,"totalTrials":95,"cells":2929},"Psilocybin therapy",{"EARLY_PHASE1":2930,"PHASE1":2932,"PHASE2":2934,"PHASE3":2936,"PHASE4":2938,"NA":2940},{"trials":2931,"activeCount":99},[],{"trials":2933,"activeCount":99},[],{"trials":2935,"activeCount":99},[],{"trials":2937,"activeCount":99},[],{"trials":2939,"activeCount":99},[],{"trials":2941,"activeCount":99},[2942],{"nctId":2943,"briefTitle":2944,"status":664,"phases":2945,"primaryCompletion":1895,"completion":2946,"start":2947,"enrollment":1700,"conditions":2948,"interventions":2951},"NCT06235411","Psilocybin in Alcohol Use Disorder With Comorbid Depression",[91],"2025-01-09","2024-02-05",[2949,1897,2950],"Alcohol-Related Disorders","Addiction",[2928,2952],"Inactive Psilocybin therapy",{"intervention":2952,"totalTrials":95,"cells":2954},{"EARLY_PHASE1":2955,"PHASE1":2957,"PHASE2":2959,"PHASE3":2961,"PHASE4":2963,"NA":2965},{"trials":2956,"activeCount":99},[],{"trials":2958,"activeCount":99},[],{"trials":2960,"activeCount":99},[],{"trials":2962,"activeCount":99},[],{"trials":2964,"activeCount":99},[],{"trials":2966,"activeCount":99},[2967],{"nctId":2943,"briefTitle":2944,"status":664,"phases":2968,"primaryCompletion":1895,"completion":2946,"start":2947,"enrollment":1700,"conditions":2969,"interventions":2970},[91],[2949,1897,2950],[2928,2952],{"intervention":2972,"totalTrials":95,"cells":2973},"Levobupivacaïne",{"EARLY_PHASE1":2974,"PHASE1":2976,"PHASE2":2978,"PHASE3":2980,"PHASE4":2982,"NA":2984},{"trials":2975,"activeCount":99},[],{"trials":2977,"activeCount":99},[],{"trials":2979,"activeCount":99},[],{"trials":2981,"activeCount":99},[],{"trials":2983,"activeCount":99},[],{"trials":2985,"activeCount":99},[2986],{"nctId":2987,"briefTitle":2988,"status":664,"phases":2989,"primaryCompletion":2990,"completion":2990,"start":2991,"enrollment":27,"conditions":2992,"interventions":2994},"NCT04011839","Evaluation of Perineural Catheterization Practices in Postoperative Orthopedic Surgery",[],"2022-06-29","2021-06-07",[2993],"Analgesia",[2972],{"intervention":2996,"totalTrials":95,"cells":2997},"TNF alpha blockers",{"EARLY_PHASE1":2998,"PHASE1":3000,"PHASE2":3002,"PHASE3":3004,"PHASE4":3006,"NA":3008},{"trials":2999,"activeCount":99},[],{"trials":3001,"activeCount":99},[],{"trials":3003,"activeCount":99},[],{"trials":3005,"activeCount":99},[],{"trials":3007,"activeCount":99},[],{"trials":3009,"activeCount":99},[3010],{"nctId":3011,"briefTitle":3012,"status":664,"phases":3013,"primaryCompletion":938,"start":3014,"enrollment":2528,"conditions":3015,"interventions":3016},"NCT02927509","Evaluation of Tumour Necrosis Factor Alpha (TNFα) Blockers in Early Rheumatoid Arthritis in France",[],"2014-05",[2530],[2996],{"intervention":3018,"totalTrials":95,"cells":3019},"Bloodwork, baseline",{"EARLY_PHASE1":3020,"PHASE1":3022,"PHASE2":3024,"PHASE3":3026,"PHASE4":3028,"NA":3030},{"trials":3021,"activeCount":99},[],{"trials":3023,"activeCount":99},[],{"trials":3025,"activeCount":99},[],{"trials":3027,"activeCount":99},[],{"trials":3029,"activeCount":99},[],{"trials":3031,"activeCount":99},[3032],{"nctId":3033,"briefTitle":3034,"status":664,"phases":3035,"primaryCompletion":3036,"completion":3036,"start":3037,"enrollment":3038,"conditions":3039,"interventions":3048},"NCT01736826","Free DNA and Nucleosome Concentrations in Pathological Pregnancies",[],"2017-12-11","2015-06",137,[3040,3041,1753,3042,3043,3044,3045,3046,3047],"Pregnancy","Venous Thrombosis","Hypertension, Pregnancy-Induced","Eclampsia","HELLP Syndrome","Pre-Eclampsia","Fetal Death","Placental Insufficiency",[3018,3049,3050],"Blood work, Months 1 & 2","Bloodwork, Months -1 to -6",{"intervention":3049,"totalTrials":95,"cells":3052},{"EARLY_PHASE1":3053,"PHASE1":3055,"PHASE2":3057,"PHASE3":3059,"PHASE4":3061,"NA":3063},{"trials":3054,"activeCount":99},[],{"trials":3056,"activeCount":99},[],{"trials":3058,"activeCount":99},[],{"trials":3060,"activeCount":99},[],{"trials":3062,"activeCount":99},[],{"trials":3064,"activeCount":99},[3065],{"nctId":3033,"briefTitle":3034,"status":664,"phases":3066,"primaryCompletion":3036,"completion":3036,"start":3037,"enrollment":3038,"conditions":3067,"interventions":3068},[],[3040,3041,1753,3042,3043,3044,3045,3046,3047],[3018,3049,3050],{"intervention":3050,"totalTrials":95,"cells":3070},{"EARLY_PHASE1":3071,"PHASE1":3073,"PHASE2":3075,"PHASE3":3077,"PHASE4":3079,"NA":3081},{"trials":3072,"activeCount":99},[],{"trials":3074,"activeCount":99},[],{"trials":3076,"activeCount":99},[],{"trials":3078,"activeCount":99},[],{"trials":3080,"activeCount":99},[],{"trials":3082,"activeCount":99},[3083],{"nctId":3033,"briefTitle":3034,"status":664,"phases":3084,"primaryCompletion":3036,"completion":3036,"start":3037,"enrollment":3038,"conditions":3085,"interventions":3086},[],[3040,3041,1753,3042,3043,3044,3045,3046,3047],[3018,3049,3050],{"intervention":3088,"totalTrials":95,"cells":3089},"Nefopam",{"EARLY_PHASE1":3090,"PHASE1":3092,"PHASE2":3094,"PHASE3":3096,"PHASE4":3098,"NA":3100},{"trials":3091,"activeCount":99},[],{"trials":3093,"activeCount":99},[],{"trials":3095,"activeCount":99},[],{"trials":3097,"activeCount":99},[],{"trials":3099,"activeCount":99},[],{"trials":3101,"activeCount":99},[3102],{"nctId":3103,"briefTitle":3104,"status":664,"phases":3105,"primaryCompletion":3106,"completion":3106,"start":3107,"enrollment":3108,"conditions":3109,"interventions":3112},"NCT03619538","Interest of the Nefopam and PCA Morphine Combination for Postoperative Analgesia in Patients Undergoing Colon Surgery",[91],"2007-06-25","2007-06",80,[3110,3111],"Colonic Neoplasms","Diverticulosis, Colonic",[3088],{"intervention":3114,"totalTrials":95,"cells":3115},"Generic antiretroviral",{"EARLY_PHASE1":3116,"PHASE1":3118,"PHASE2":3120,"PHASE3":3122,"PHASE4":3124,"NA":3126},{"trials":3117,"activeCount":99},[],{"trials":3119,"activeCount":99},[],{"trials":3121,"activeCount":99},[],{"trials":3123,"activeCount":99},[],{"trials":3125,"activeCount":99},[],{"trials":3127,"activeCount":99},[3128],{"nctId":3129,"briefTitle":3130,"status":664,"phases":3131,"primaryCompletion":3132,"completion":3133,"start":3134,"enrollment":1725,"conditions":3135,"interventions":3137},"NCT04274595","Role of Reverse Transcriptase Inhibitors in the Treatment of Psoriasis",[91],"2021-11-29","2022-06-20","2020-02-13",[3136],"Psoriasis",[3114],{"intervention":3139,"totalTrials":95,"cells":3140},"Classification as \"asthmatic\" or \"rhinitis only\" via proteomic analysis",{"EARLY_PHASE1":3141,"PHASE1":3143,"PHASE2":3145,"PHASE3":3147,"PHASE4":3149,"NA":3151},{"trials":3142,"activeCount":99},[],{"trials":3144,"activeCount":99},[],{"trials":3146,"activeCount":99},[],{"trials":3148,"activeCount":99},[],{"trials":3150,"activeCount":99},[],{"trials":3152,"activeCount":99},[3153],{"nctId":3154,"briefTitle":3155,"status":664,"phases":3156,"primaryCompletion":692,"completion":692,"start":3157,"enrollment":3158,"conditions":3159,"interventions":3162},"NCT01104012","Validation of Proteomic Analyses for Allergic Asthma and Rhinitis",[],"2010-05",133,[3160,3161],"Rhinitis, Allergic","Asthma, Allergic",[3139,3163],"Classification as \"asthmatic\" or \"rhinitis only\" according to a metacholine test",{"intervention":3163,"totalTrials":95,"cells":3165},{"EARLY_PHASE1":3166,"PHASE1":3168,"PHASE2":3170,"PHASE3":3172,"PHASE4":3174,"NA":3176},{"trials":3167,"activeCount":99},[],{"trials":3169,"activeCount":99},[],{"trials":3171,"activeCount":99},[],{"trials":3173,"activeCount":99},[],{"trials":3175,"activeCount":99},[],{"trials":3177,"activeCount":99},[3178],{"nctId":3154,"briefTitle":3155,"status":664,"phases":3179,"primaryCompletion":692,"completion":692,"start":3157,"enrollment":3158,"conditions":3180,"interventions":3181},[],[3160,3161],[3139,3163],{"intervention":3183,"totalTrials":95,"cells":3184},"Blood samples",{"EARLY_PHASE1":3185,"PHASE1":3187,"PHASE2":3189,"PHASE3":3191,"PHASE4":3193,"NA":3195},{"trials":3186,"activeCount":99},[],{"trials":3188,"activeCount":99},[],{"trials":3190,"activeCount":99},[],{"trials":3192,"activeCount":99},[],{"trials":3194,"activeCount":99},[],{"trials":3196,"activeCount":99},[3197],{"nctId":3198,"briefTitle":3199,"status":664,"phases":3200,"primaryCompletion":3201,"completion":3201,"start":3202,"enrollment":737,"conditions":3203,"interventions":3205},"NCT02317133","Study of the Role of Regulator T Cells in the Pathophysiology of Childhood Henoch Schönlein Purpura",[],"2017-07-12","2015-02",[3204],"Henoch Schönlein Purpura",[3183,3206],"Stool samples",{"intervention":3206,"totalTrials":95,"cells":3208},{"EARLY_PHASE1":3209,"PHASE1":3211,"PHASE2":3213,"PHASE3":3215,"PHASE4":3217,"NA":3219},{"trials":3210,"activeCount":99},[],{"trials":3212,"activeCount":99},[],{"trials":3214,"activeCount":99},[],{"trials":3216,"activeCount":99},[],{"trials":3218,"activeCount":99},[],{"trials":3220,"activeCount":99},[3221],{"nctId":3198,"briefTitle":3199,"status":664,"phases":3222,"primaryCompletion":3201,"completion":3201,"start":3202,"enrollment":737,"conditions":3223,"interventions":3224},[],[3204],[3183,3206],{"intervention":3226,"totalTrials":95,"cells":3227},"Circulatory shock with norepinephrine in ICU",{"EARLY_PHASE1":3228,"PHASE1":3230,"PHASE2":3232,"PHASE3":3234,"PHASE4":3236,"NA":3238},{"trials":3229,"activeCount":99},[],{"trials":3231,"activeCount":99},[],{"trials":3233,"activeCount":99},[],{"trials":3235,"activeCount":99},[],{"trials":3237,"activeCount":99},[],{"trials":3239,"activeCount":99},[3240],{"nctId":3241,"briefTitle":3242,"status":664,"phases":3243,"primaryCompletion":666,"completion":666,"start":3244,"enrollment":737,"conditions":3245,"interventions":3247},"NCT05032261","ICU Norepinephrine Load",[],"2021-09-01",[3246],"Circulatory Collapse and Shock",[3226],{"intervention":3249,"totalTrials":95,"cells":3250},"Treatment with high-dose ceftobiprole (500mg loading dose followed by 2.5g under continuos infusion).",{"EARLY_PHASE1":3251,"PHASE1":3253,"PHASE2":3255,"PHASE3":3257,"PHASE4":3259,"NA":3261},{"trials":3252,"activeCount":99},[],{"trials":3254,"activeCount":99},[],{"trials":3256,"activeCount":99},[],{"trials":3258,"activeCount":99},[],{"trials":3260,"activeCount":99},[],{"trials":3262,"activeCount":99},[3263],{"nctId":3264,"briefTitle":3265,"status":664,"phases":3266,"primaryCompletion":1313,"completion":1313,"start":3267,"enrollment":16,"conditions":3268,"interventions":3270},"NCT04171674","Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.",[91],"2021-04-01",[3269],"Pneumonia",[3249],{"intervention":3272,"totalTrials":95,"cells":3273},"Wrist anesthesia",{"EARLY_PHASE1":3274,"PHASE1":3276,"PHASE2":3278,"PHASE3":3280,"PHASE4":3282,"NA":3284},{"trials":3275,"activeCount":99},[],{"trials":3277,"activeCount":99},[],{"trials":3279,"activeCount":99},[],{"trials":3281,"activeCount":99},[],{"trials":3283,"activeCount":99},[],{"trials":3285,"activeCount":99},[3286],{"nctId":3287,"briefTitle":3288,"status":664,"phases":3289,"primaryCompletion":3290,"completion":3290,"start":3291,"enrollment":286,"conditions":3292,"interventions":3294},"NCT02610647","Functional Significance of Complexity Measures in the Sensory-motor Behavior",[91],"2017-08-31","2017-06-06",[3293],"Healthy Volunteers",[3272],{"intervention":3296,"totalTrials":95,"cells":3297},"immediate post operative bioassay of Parathyroid Hormone",{"EARLY_PHASE1":3298,"PHASE1":3300,"PHASE2":3302,"PHASE3":3304,"PHASE4":3306,"NA":3308},{"trials":3299,"activeCount":99},[],{"trials":3301,"activeCount":99},[],{"trials":3303,"activeCount":99},[],{"trials":3305,"activeCount":99},[],{"trials":3307,"activeCount":99},[],{"trials":3309,"activeCount":99},[3310],{"nctId":3311,"briefTitle":3312,"status":664,"phases":3313,"primaryCompletion":3314,"completion":3314,"start":3315,"enrollment":380,"conditions":3316,"interventions":3318},"NCT02924532","Postoperative Dose of Parathyroid Hormone as a Marker for the Occurrence of Hypoparathyroidism After Total Thyroidectomy",[],"2018-12-31","2012-02",[3317],"Hypoparathyroidism",[3296],{"intervention":3320,"totalTrials":95,"cells":3321},"Blood work in the ambulance",{"EARLY_PHASE1":3322,"PHASE1":3324,"PHASE2":3326,"PHASE3":3328,"PHASE4":3330,"NA":3332},{"trials":3323,"activeCount":99},[],{"trials":3325,"activeCount":99},[],{"trials":3327,"activeCount":99},[],{"trials":3329,"activeCount":99},[],{"trials":3331,"activeCount":99},[],{"trials":3333,"activeCount":99},[3334],{"nctId":3335,"briefTitle":3336,"status":664,"phases":3337,"primaryCompletion":3338,"completion":3338,"start":3339,"enrollment":3340,"conditions":3341,"interventions":3343},"NCT02116426","Copeptin Testing During Pre-hospital Care in the Treatment of Chest Pain Suggestive of Acute Coronary Syndrome",[],"2017-08-01","2015-07-29",320,[3342],"Chest Pain",[3320,3344,3345],"Blood work upon arrival in the emergency room","Blood work at 3 hours post-arrival in the emergency room",{"intervention":3344,"totalTrials":95,"cells":3347},{"EARLY_PHASE1":3348,"PHASE1":3350,"PHASE2":3352,"PHASE3":3354,"PHASE4":3356,"NA":3358},{"trials":3349,"activeCount":99},[],{"trials":3351,"activeCount":99},[],{"trials":3353,"activeCount":99},[],{"trials":3355,"activeCount":99},[],{"trials":3357,"activeCount":99},[],{"trials":3359,"activeCount":99},[3360],{"nctId":3335,"briefTitle":3336,"status":664,"phases":3361,"primaryCompletion":3338,"completion":3338,"start":3339,"enrollment":3340,"conditions":3362,"interventions":3363},[],[3342],[3320,3344,3345],{"intervention":3345,"totalTrials":95,"cells":3365},{"EARLY_PHASE1":3366,"PHASE1":3368,"PHASE2":3370,"PHASE3":3372,"PHASE4":3374,"NA":3376},{"trials":3367,"activeCount":99},[],{"trials":3369,"activeCount":99},[],{"trials":3371,"activeCount":99},[],{"trials":3373,"activeCount":99},[],{"trials":3375,"activeCount":99},[],{"trials":3377,"activeCount":99},[3378],{"nctId":3335,"briefTitle":3336,"status":664,"phases":3379,"primaryCompletion":3338,"completion":3338,"start":3339,"enrollment":3340,"conditions":3380,"interventions":3381},[],[3342],[3320,3344,3345],{"intervention":3383,"totalTrials":95,"cells":3384},"Post-partum oral glucose tolerance test",{"EARLY_PHASE1":3385,"PHASE1":3387,"PHASE2":3389,"PHASE3":3391,"PHASE4":3393,"NA":3395},{"trials":3386,"activeCount":99},[],{"trials":3388,"activeCount":99},[],{"trials":3390,"activeCount":99},[],{"trials":3392,"activeCount":99},[],{"trials":3394,"activeCount":99},[],{"trials":3396,"activeCount":99},[3397],{"nctId":3398,"briefTitle":3399,"status":664,"phases":3400,"primaryCompletion":3401,"completion":3401,"start":3402,"enrollment":3403,"conditions":3404,"interventions":3408},"NCT01839448","Abnormal Post-partum Glucose Metabolism After Gestational Diabetes Diagnosed Before or After 24 Weeks of Gestation",[],"2016-10-12","2014-03-27",500,[3405,3406,3407],"Gestational Diabetes","Type 2 Diabetes","Glucose Intolerance",[3383],{"intervention":3410,"totalTrials":95,"cells":3411},"PRP-L",{"EARLY_PHASE1":3412,"PHASE1":3414,"PHASE2":3416,"PHASE3":3418,"PHASE4":3420,"NA":3422},{"trials":3413,"activeCount":99},[],{"trials":3415,"activeCount":99},[],{"trials":3417,"activeCount":99},[],{"trials":3419,"activeCount":99},[],{"trials":3421,"activeCount":99},[],{"trials":3423,"activeCount":99},[3424],{"nctId":3425,"briefTitle":3426,"status":1202,"phases":3427,"primaryCompletion":3428,"completion":3428,"start":3429,"enrollment":3430,"conditions":3431,"interventions":3434},"NCT02325063","Evaluation of Three Types of Injection for the Treatment of Lateral Epicondylalgia",[91],"2017-05-02","2015-12-17",13,[3432,3433],"Epicondylitis, Lateral Humeral","Tennis Elbow",[3410,3435,3436],"Botox","Corticoid",{"intervention":3435,"totalTrials":95,"cells":3438},{"EARLY_PHASE1":3439,"PHASE1":3441,"PHASE2":3443,"PHASE3":3445,"PHASE4":3447,"NA":3449},{"trials":3440,"activeCount":99},[],{"trials":3442,"activeCount":99},[],{"trials":3444,"activeCount":99},[],{"trials":3446,"activeCount":99},[],{"trials":3448,"activeCount":99},[],{"trials":3450,"activeCount":99},[3451],{"nctId":3425,"briefTitle":3426,"status":1202,"phases":3452,"primaryCompletion":3428,"completion":3428,"start":3429,"enrollment":3430,"conditions":3453,"interventions":3454},[91],[3432,3433],[3410,3435,3436],{"intervention":3436,"totalTrials":95,"cells":3456},{"EARLY_PHASE1":3457,"PHASE1":3459,"PHASE2":3461,"PHASE3":3463,"PHASE4":3465,"NA":3467},{"trials":3458,"activeCount":99},[],{"trials":3460,"activeCount":99},[],{"trials":3462,"activeCount":99},[],{"trials":3464,"activeCount":99},[],{"trials":3466,"activeCount":99},[],{"trials":3468,"activeCount":99},[3469],{"nctId":3425,"briefTitle":3426,"status":1202,"phases":3470,"primaryCompletion":3428,"completion":3428,"start":3429,"enrollment":3430,"conditions":3471,"interventions":3472},[91],[3432,3433],[3410,3435,3436],{"intervention":3474,"totalTrials":95,"cells":3475},"Anesthesia with Xenon",{"EARLY_PHASE1":3476,"PHASE1":3478,"PHASE2":3480,"PHASE3":3482,"PHASE4":3484,"NA":3486},{"trials":3477,"activeCount":99},[],{"trials":3479,"activeCount":99},[],{"trials":3481,"activeCount":99},[],{"trials":3483,"activeCount":99},[],{"trials":3485,"activeCount":99},[],{"trials":3487,"activeCount":99},[3488],{"nctId":3489,"briefTitle":3490,"status":664,"phases":3491,"primaryCompletion":3202,"completion":3202,"start":3492,"enrollment":3493,"conditions":3494,"interventions":3496},"NCT01404819","Evaluation of Brain Damage Resulting From Carotid Endarterectomy With Xenon Anesthesia",[91],"2012-04",86,[3495],"Carotid Endarterectomy",[3474,3497],"Standard anesthesia",{"intervention":3497,"totalTrials":95,"cells":3499},{"EARLY_PHASE1":3500,"PHASE1":3502,"PHASE2":3504,"PHASE3":3506,"PHASE4":3508,"NA":3510},{"trials":3501,"activeCount":99},[],{"trials":3503,"activeCount":99},[],{"trials":3505,"activeCount":99},[],{"trials":3507,"activeCount":99},[],{"trials":3509,"activeCount":99},[],{"trials":3511,"activeCount":99},[3512],{"nctId":3489,"briefTitle":3490,"status":664,"phases":3513,"primaryCompletion":3202,"completion":3202,"start":3492,"enrollment":3493,"conditions":3514,"interventions":3515},[91],[3495],[3474,3497]]